Otorhinolaryngologic disease
MONDO:0024623Pathological processes of the ear, the nose, and the throat, also known as the ENT diseases.
Also known as: ear, nose and throat disorder, ear, nose or throat disorder, ear/nose/throat disease, otolaryngologic disorder, otorhinolaryngologic disease, ENT disease, ENT diseases, disease, ENT
1238 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 459 trials in this tab.
-
Robotic surgery may spare throat cancer patients from chemo and radiation
⭐️ CURE ⭐️ Recruiting nowThis phase 2 trial is testing whether robotic surgery alone can control HPV-related throat cancer, potentially sparing patients the long-term side effects of chemotherapy and radiation. The study enrolls people with HPV-positive oropharyngeal cancer whose tumors are removable and…
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: ⭐️ CURE ⭐️
Last updated Jul 24, 2026 00:00 UTC
-
Could a dengue vaccine be safe for autoimmune patients? new trial aims to find out
⭐️ VACCINE ⭐️ Recruiting nowThis study tests whether the Butantan-Dengue vaccine is safe and works well in people aged 12–59 with autoimmune rheumatic diseases (like rheumatoid arthritis or lupus) who are stable on low or no immune-suppressing drugs. Participants receive one vaccine dose and are monitored f…
Phase: PHASE4 • Sponsor: University of Sao Paulo General Hospital • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 22, 2026 00:00 UTC
-
New combo aims to shrink tumors and cut radiation for young cancer patients
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug nivolumab to standard chemotherapy (gemcitabine and cisplatin) before radiation therapy is safe and effective for children and young adults (up to age 21) with newly diagnosed nasopharyngeal carcinoma. The goal is to see if t…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Less neck surgery may spare shoulder function in oral cancer patients
Disease control Recruiting nowThis study tests whether a less invasive surgery called sentinel lymph node biopsy can replace standard neck dissection for early-stage oral cavity cancer. About 686 patients will be randomly assigned to one of the two procedures. The goal is to see if the gentler approach mainta…
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
New hope for head and neck cancer: which drug works best with radiation?
Disease control Recruiting nowThis study compares two treatments for people with advanced head and neck cancer who cannot use the standard drug cisplatin. About 454 participants will receive either cetuximab (a targeted antibody) or a chemotherapy combo (carboplatin + paclitaxel) alongside precise radiation t…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Biomarker-Guided combo aims to outsmart tough cancers
Disease control Recruiting nowThis phase II trial is testing whether the combination of cabozantinib (a targeted therapy) and nivolumab (an immunotherapy) can shrink or stabilize advanced melanoma and head and neck cancers that have stopped responding to prior immunotherapy. Researchers are also checking if t…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a tiny ear tube offer lasting relief for middle ear infections?
Disease control Recruiting nowThis study is checking how well the Solo+ tympanostomy tube works in people with middle ear infections. Researchers will review doctor notes, monitor how the tubes function after surgery, and ask patients or their parents about their experience. The goal is to gather real-world i…
Sponsor: AventaMed DAC • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a blood test and MRI tailor cancer therapy to each patient?
Disease control Recruiting nowThis trial tests whether giving extra chemotherapy or a combination of chemotherapy and immunotherapy after standard treatment can improve outcomes for people with nasopharyngeal carcinoma. The choice of treatment is based on each patient's risk level, determined by changes in a …
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a new immune drug outsmart Hard-to-Treat tumors?
Disease control Recruiting nowThis trial tests an experimental drug called STAR0602, which is designed to help the immune system attack cancer cells. It is being studied in people with advanced solid tumors that have not responded to standard treatments. The drug is given alone or combined with chemotherapy, …
Phase: PHASE1, PHASE2 • Sponsor: Marengo Therapeutics, Inc. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New combo therapy aims to stop head and neck cancer from returning
Disease control Recruiting nowThis phase II trial is testing whether adding chemotherapy or chemo-immunotherapy before standard salvage surgery can improve outcomes for patients with PD-L1 positive head and neck cancer that has come back. About 180 participants will receive either carboplatin and paclitaxel, …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Blood test may spare throat cancer patients from full radiation
Disease control Recruiting nowThis trial is testing whether a blood test that detects HPV DNA can help doctors safely reduce the amount of radiation given after surgery for HPV-positive throat cancer. After surgery, patients with undetectable HPV DNA in their blood may receive a lower dose of radiation, while…
Phase: NA • Sponsor: Indiana University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Double immunotherapy may keep nasopharyngeal cancer at bay
Disease control Recruiting nowThis phase II trial tests whether adding the immunotherapy drug relatlimab to standard nivolumab maintenance therapy can extend the time before cancer grows or spreads in patients with recurrent or metastatic nasopharyngeal cancer linked to Epstein-Barr virus. Participants first …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a new pill help the immune system fight cancer?
Disease control Recruiting nowThis trial is testing an investigational drug called ARV-6723, given as a pill, in people with advanced solid tumors. The drug is designed to help the immune system recognize and attack cancer cells. The study will test ARV-6723 alone and in combination with pembrolizumab, an imm…
Phase: PHASE1, PHASE2 • Sponsor: Arvinas Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug EVOLVE104 takes on tough cancers in early human trial
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called EVOLVE104 in people with advanced bladder cancer or several types of squamous cell carcinoma (lung, esophagus, skin, and others). The study aims to find a safe dose and see if the drug can shrink tumors. It is for pati…
Phase: PHASE1 • Sponsor: EvolveImmune United, Inc • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a simple antibiotic course fight oral cancer from the inside?
Disease control Recruiting nowThis study is testing whether taking the antibiotic metronidazole and using a chlorhexidine mouth rinse for 10 days before surgery can lower the amount of bacteria living inside oral cancer tumors. The researchers will compare bacteria levels before and after treatment in 30 adul…
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Blood test may tailor throat cancer treatment, sparing patients from harsh side effects
Disease control Recruiting nowThis trial tests whether a blood test that detects HPV DNA can help doctors personalize treatment for people with HPV-related throat cancer. Participants receive radiation therapy, with or without chemotherapy, but the intensity is adjusted based on their blood test results and c…
Phase: PHASE2 • Sponsor: Jonathan Schoenfeld, MD, MPH • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Immunotherapy before surgery: a new hope for HPV throat cancer?
Disease control Recruiting nowThis phase 2 trial is testing whether the immunotherapy drug atezolizumab, given before surgery, can help treat HPV-related throat cancer that can be removed. About 20 adults with stage I oropharyngeal cancer will receive two doses of atezolizumab followed by standard surgery. Th…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Blood test guides safer cancer treatment after surgery
Disease control Recruiting nowThis study tests whether a blood test that detects tumor DNA can help doctors choose the right amount of chemotherapy and radiation after surgery for HPV-positive throat cancer. The goal is to give less intense treatment to patients with a low risk of cancer returning, reducing s…
Phase: PHASE2 • Sponsor: Zachary Zumsteg • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New combo therapy aims to outsmart resistant head and neck cancer
Disease control Recruiting nowThis study tests whether adding cetuximab to standard immunotherapy (pembrolizumab) helps people with advanced head and neck cancer that has stopped responding to platinum chemotherapy live longer. About 158 adults with cancer that has returned or spread will receive either pembr…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Experimental drug plus radiation aims to tackle returning head and neck cancers
Disease control Recruiting nowThis early-phase trial is testing whether a drug called camonsertib, combined with a precise type of radiation, can help control head and neck cancers that have come back or cannot be removed by surgery. About 39 adults with these cancers will receive the drug along with focused …
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Less neck surgery may be just as effective for oral cancer with one affected node
Disease control Recruiting nowThis trial tests whether removing fewer lymph nodes from the neck (selective dissection, levels I-IV) works as well as the standard more extensive removal (modified dissection, levels I-V) in people with oral cancer that has spread to a single lymph node. The goal is to see if th…
Phase: NA • Sponsor: Kolhapur Cancer Centre - Cancer Centers of America • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Less may be more: testing a gentler neck dissection for oral cancer
Disease control Recruiting nowThis trial compares two types of neck surgery for people with oral cancer that has not spread to lymph nodes. One surgery removes lymph nodes from levels I to IV, while the other removes only levels I to III. The goal is to see whether the less extensive surgery can control cance…
Phase: NA • Sponsor: Kolhapur Cancer Centre - Cancer Centers of America • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Could a Two-Drug punch before surgery shrink head & neck tumors?
Disease control Recruiting nowThis study tests whether adding an experimental drug (CDX-1140) to a standard immunotherapy (cemiplimab) before surgery can shrink advanced head and neck cancers more than the immunotherapy alone. About 44 people with stage III-IV head and neck cancer will receive either the comb…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Which biologic is best for nasal polyps? new study aims to find out
Disease control Recruiting nowThis study will compare three FDA-approved biologic drugs (dupilumab, omalizumab, and mepolizumab) in 504 adults with chronic sinusitis and nasal polyps. The goal is to see which drug works best for different patients and whether simple tests can predict who will improve the most…
Phase: PHASE4 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Aiming to spare the neck: could smarter radiation cut side effects in oral cancer?
Disease control Recruiting nowThis phase II trial is testing whether a sentinel lymph node biopsy can guide radiation therapy to only one side of the neck in people with oral cavity squamous cell carcinoma. Currently, standard treatment often involves radiating both sides of the neck, which can harm saliva pr…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Sniffing your way back: does scent therapy rebuild COVID-Shattered smell?
Disease control Recruiting nowThis trial tests whether a 12-week smell training program can help people who lost their sense of smell after COVID-19. Participants will sniff four different scents twice daily, with one group using rose, orange, clove, and eucalyptus, and another using cheese, coffee, strawberr…
Phase: NA • Sponsor: Université du Québec à Trois-Rivières • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Could immunotherapy replace Chemo-Radiation after head and neck cancer surgery?
Disease control Recruiting nowThis phase II trial is testing whether the immunotherapy drug pembrolizumab (Keytruda) alone can work better than the usual combination of chemotherapy and radiation after surgery for head and neck cancer that has come back or is a new primary tumor. About 188 adults aged 18-79 w…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New balloon could keep sinus patients out of the operating room
Disease control Recruiting nowThis study tests whether a balloon coated with the drug paclitaxel, used during standard sinus surgery, can reduce the need for additional procedures or medications in adults with chronic sinusitis. About 300 participants will receive either the drug-coated balloon or a plain bal…
Phase: NA • Sponsor: Airiver Medical, Inc. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New drug combo aims to shrink mouth cancer before surgery
Disease control Recruiting nowThis phase 2 trial tests whether giving two drugs, cemiplimab and cetuximab, before salvage surgery can help control recurrent oral cavity squamous cell carcinoma. The study involves 17 adults whose cancer has returned at least 3 months after prior treatment. Researchers will mon…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New antibody combo aims to supercharge immune system against Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial is testing an experimental drug called INBRX-106, alone or combined with the immunotherapy Keytruda, in people with advanced solid tumors (including lung, head and neck, melanoma, and others) that have stopped responding to standard treatments. The main goa…
Phase: PHASE1, PHASE2 • Sponsor: Inhibrx Biosciences, Inc • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a common antibiotic beat MRSA in kids? a trial puts TMP-SMX to the test
Disease control Recruiting nowThis trial compares two oral antibiotics—trimethoprim-sulfamethoxazole (TMP-SMX) and clindamycin—to see which works better for children with invasive MRSA infections, such as bone, joint, or deep tissue infections. About 100 children aged 60 days to 18 years will take one of the …
Phase: PHASE4 • Sponsor: Indiana University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New study tests tezepelumab for chronic sinusitis sufferers
Disease control Recruiting nowThis study follows 200 adults with severe chronic sinusitis and nasal polyps who are starting tezepelumab as part of their routine care. Researchers will track changes in symptoms and quality of life over up to two years using patient questionnaires. The goal is to see how well t…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Tailored radiation aims to shrink tumors, spare healthy tissue in nasopharyngeal cancer
Disease control Recruiting nowThis phase 3 trial tests whether a personalized radiation plan, which expands the treatment area based on each patient's tumor margins, can control nasopharyngeal cancer as well as the standard approach. The study includes 568 adults with newly diagnosed, non-metastatic disease. …
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New drug duo aims to make inoperable sinus cancer removable
Disease control Recruiting nowThis phase 2 trial tests a combination of two drugs—becotatug vedotin (a targeted antibody-drug conjugate) and epirubicin (a standard chemo)—in 40 people with EGFR-positive, recurrent sinonasal adenoid cystic carcinoma that cannot be surgically removed. The goal is to shrink the …
Phase: PHASE2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Nanoparticle steroid spray could transform recovery after sinus surgery
Disease control Recruiting nowThis trial tests a new nanoparticle spray containing the steroid triamcinolone acetonide for people recovering from endoscopic sinus surgery. The spray is designed to deliver the drug directly to the nasal cavity to reduce inflammation and improve healing. Researchers compare it …
Phase: PHASE2 • Sponsor: Deraya University • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can less be more? new trial aims to cut harsh side effects in HPV throat cancer treatment
Disease control Recruiting nowThis study is for people with HPV-related throat cancer. After surgery, patients receive lower-than-standard doses of radiation and sometimes chemotherapy, based on their risk level. The goal is to keep cancer from coming back while reducing side effects like weight loss. About 1…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New combo therapy offers hope for hard-to-treat nose cancer
Disease control Recruiting nowThis study tests a new treatment for people whose nose and throat cancer has returned and cannot be removed with surgery. The treatment combines an immunotherapy drug (PD-1 antibody) with two chemotherapy drugs, followed by targeted radiation. The goal is to see if this approach …
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug duo aims to shrink tough cancers
Disease control Recruiting nowThis study tests a new drug called BL-B01D1 combined with an immunotherapy (PD-1 antibody) in people with advanced lung cancer, nasopharyngeal cancer, or other solid tumors that have spread. The goal is to see if the combination can shrink tumors and control the disease. About 57…
Phase: PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could less be more? trial tests reduced radiation and chemo after surgery for HPV-Linked throat cancer
Disease control Recruiting nowThis trial studies people with HPV-positive oropharynx cancer whose tumors can be surgically removed. After surgery, patients are grouped by risk: low-risk patients get no further treatment, intermediate-risk get a lower dose of radiation, and high-risk get lower-dose radiation p…
Phase: PHASE2 • Sponsor: Heath Skinner • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New ear tube robot could make surgery quicker and safer for kids
Disease control Recruiting nowThis study tests a new handheld device called CLiKX that helps doctors place ear tubes in children and adults with chronic ear infections or fluid buildup. The device uses sensors and controlled force to make the procedure more precise. Researchers will check if the tube is place…
Phase: NA • Sponsor: ClinQure, Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug aims to supercharge immune system against HPV throat cancer
Disease control Recruiting nowThis study tests an experimental drug called CUE-101 in 30 people with HPV16-positive throat cancer. The drug is given before standard treatments like surgery or chemoradiation to see if it safely boosts the body's immune cells to fight the cancer. Researchers will monitor side e…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a simple breathing device help children speak more clearly without surgery?
Disease control Recruiting nowThis study tests whether a handheld device that strengthens the muscles used for breathing and swallowing can improve speech in children aged 5 to 17 with velopharyngeal dysfunction, a condition where the soft palate does not close properly, causing nasal-sounding speech. Partici…
Phase: NA • Sponsor: Noel Jabbour • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Promising drug cocktail aims to save voice boxes in throat cancer patients
Disease control Recruiting nowThis phase II trial tests two drugs—becotatug vedotin and pucotenlimab—given before surgery to people with advanced hypopharyngeal cancer. The goal is to shrink tumors enough to improve surgical outcomes and possibly preserve the voice box. About 52 participants will receive thre…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a 'Sandwich' of drugs beat Full-Course immunotherapy for a tough head and neck cancer?
Disease control Recruiting nowThis phase III trial tests whether a shorter, 'immune sandwich' regimen works as well as full-course immunotherapy for locally advanced nasopharyngeal carcinoma. The experimental group gets induction chemotherapy plus two immune-targeting drugs (toripalimab and nimotuzumab), then…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Vaccine combo aims to supercharge immune attack on HPV-Positive throat cancer
Disease control Recruiting nowThis study tests whether adding two experimental HPV vaccines (pBI-11 and TA-HPV) to the standard immunotherapy drug pembrolizumab can shrink tumors or slow cancer growth in people with advanced oropharyngeal cancer that is HPV-positive. About 54 adults whose cancer has returned …
Phase: PHASE2 • Sponsor: Michael K. Gibson • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New hope for uveitis: Anti-Inflammatory drug tested in chinese patients
Disease control Recruiting nowThis study tests the drug adalimumab (Tebiovio®) in 30 adults with non-infectious uveitis, an inflammatory eye disease. The goal is to see if the drug can control inflammation and prevent treatment failure. Participants will receive injections and be monitored for up to 24 weeks.…
Phase: PHASE4 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug duo aims to keep advanced nasopharyngeal cancer in check
Disease control Recruiting nowThis Phase III trial tests whether adding an experimental drug called becotatug vedotin to standard anti-PD1 immunotherapy can better control advanced nasopharyngeal carcinoma that has spread or returned. About 86 adults whose cancer has stabilized after initial chemoimmunotherap…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug cocktail targets Virus-Linked cancers in early trial
Disease control Recruiting nowThis phase 1 study tests a combination of two drugs, pomalidomide (a pill) and nivolumab (an infusion), in adults with cancers caused by viruses like Epstein-Barr, HPV, or hepatitis. The goal is to find a safe dose and see if the drugs can shrink tumors. Up to 58 people with Kapo…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could less radiation be better for HPV throat cancer?
Disease control Recruiting nowThis study tests whether giving a lower dose of radiation to the lymph nodes in the neck that are not directly affected by cancer can reduce side effects while still curing the disease. It includes 100 people with early-stage HPV-related throat cancer. The goal is to maintain exc…
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Double-Targeting antibody takes on Hard-to-Treat throat cancer
Disease control Recruiting nowThis trial tests a new drug called JS207, a bispecific antibody that targets two proteins (PD1 and VEGF) involved in cancer growth and immune evasion. It is being studied in people with recurrent or metastatic nasopharyngeal carcinoma, a type of throat cancer, who have already tr…
Phase: PHASE2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Antiviral drug ganciclovir explored as new weapon against stubborn allergies
Disease control Recruiting nowThis trial investigates whether the antiviral drug ganciclovir can help people with moderate-to-severe allergic rhinitis that doesn't improve with standard treatments. Participants receive either ganciclovir capsules or a placebo for two weeks, alongside a nasal steroid spray. Re…
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Experimental vaccine aims to tame rare throat tumor disease
Disease control Recruiting nowThis early-stage trial tests a custom-made vaccine for recurrent respiratory papillomatosis (RRP), a rare condition where non-cancerous growths keep coming back in the throat. The vaccine is made from each patient's own immune cells and designed to target the virus that causes RR…
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can a gene test guide better treatment for head and neck cancer survivors?
Disease control Recruiting nowThis study compares two treatments after surgery for stage III-IVA head and neck cancer: radiation alone versus radiation plus the chemotherapy drug cisplatin. The goal is to see which approach better prevents the cancer from returning, especially in patients with certain TP53 ge…
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Vaccine trains immune system to fight HPV-Positive head and neck tumors
Disease control Recruiting nowThis trial tests a vaccine called BVAC-E6E7 in people with head and neck cancer linked to HPV types 16 or 18 that cannot be removed by surgery or has spread. The vaccine is designed to teach the immune system to attack cancer cells. The study first checks safety and the best dose…
Phase: PHASE1, PHASE2 • Sponsor: Cellid Co., Ltd. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New drug combo aims to shrink oral cancers before surgery
Disease control Recruiting nowThis trial investigates whether adding ivonescimab—a drug that targets both PD-1 and VEGF—to standard chemotherapy can shrink locally advanced oral or oropharyngeal cancers before surgery. About 20 adults with resectable stage II–IVA disease will receive two cycles of the combina…
Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Bionic ear for balance? new implant aims to steady wobbly patients
Disease control Recruiting nowThis study is testing an experimental device called a vestibular implant, which is surgically placed behind the ear to stimulate the balance nerve. The goal is to see if it can improve walking and balance in adults with long-term dizziness that hasn't improved with other treatmen…
Phase: NA • Sponsor: Cochlear • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Immune booster after standard therapy may stall nasopharyngeal cancer
Disease control Recruiting nowThis phase 2 trial tests whether the immunotherapy drug nivolumab can improve outcomes for people with locally advanced nasopharyngeal carcinoma who still have signs of cancer after standard chemoradiotherapy. About 57 adults aged 19 and older will receive nivolumab infusions eve…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New radiation approach aims to spare healthy tissue in sinus cancer treatment
Disease control Recruiting nowThis Phase 2 trial tests a new way to give radiation for sinus cancer after endoscopic surgery. Instead of radiating the whole sinus area, doctors will use a 'dose painting' technique that targets only the areas where cancer was found. The goal is to see if this reduces side effe…
Phase: PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Custom cochlear implant tuning based on ear shape may boost hearing
Disease control Recruiting nowThis study tests whether programming a cochlear implant based on each person's unique inner ear structure improves hearing compared to the standard one-size-fits-all approach. Adults with severe to profound hearing loss who already have a MED-EL cochlear implant will receive both…
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug combo aims to reduce surgeries for rare HPV throat condition
Disease control Recruiting nowThis early-phase study tests two cancer drugs—lenvatinib (a daily pill) and pembrolizumab (an IV infusion)—in 20 adults with HPV-related recurrent respiratory papillomatosis (RRP) that has spread to the lungs. The goal is to see if the combination can shrink papillomas and reduce…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Blood test may let some throat cancer patients skip radiation after surgery
Disease control Recruiting nowThis study is for people with HPV-related throat cancer who have surgery to remove the tumor. Normally, some patients also get radiation afterward to lower the risk of cancer coming back. This trial tests whether it's safe to skip that radiation if a blood test two weeks after su…
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Dog allergy vaccine shows promise in small swedish trial
Disease control Recruiting nowThis study tests a dog allergy immunotherapy called Alutard SQ Dog in 40 adults with moderate-to-severe dog allergy. Participants receive increasing doses over 13 weeks, then maintenance shots every 6-8 weeks for a year. Their symptoms and lung function are measured before and af…
Phase: PHASE4 • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New allergy shot aims to tame mugwort season in just four weeks
Disease control Recruiting nowThis Phase 2 trial tests PollenVax, a new immunotherapy for people with moderate-to-severe allergic rhinitis caused by mugwort pollen. The treatment is given as four weekly shots before the pollen season. Researchers will compare symptom scores and medication use between the Poll…
Phase: PHASE2 • Sponsor: Kazakh National Agrarian University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug combo aims to boost radiation success in EBV-related throat cancer
Disease control Recruiting nowThis study tests whether giving three drugs (gemcitabine, docetaxel, and toripalimab) before standard radiation can safely improve outcomes for people with a specific throat cancer caused by the Epstein-Barr virus. About 24 adults with advanced but not spread cancer will receive …
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Custom 3D-Printed titanium implants could rebuild faces after injury or surgery
Disease control Recruiting nowThis study tests whether custom 3D-printed titanium implants can safely and effectively rebuild facial bones in 30 adults with defects from injury, cancer surgery, or birth conditions. Each implant is designed from CT scans to match the patient's unique anatomy. Researchers will …
Phase: NA • Sponsor: Tishreen University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could less radiation be just as good for some throat cancers?
Disease control Recruiting nowThis study looks at whether people with a type of throat cancer linked to the Epstein-Barr virus can safely receive lower doses of radiation after initial chemotherapy. The goal is to see if reducing radiation can still control the cancer while causing fewer long-term side effect…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental immune therapy aims to tackle HPV cancers before standard care
Disease control Recruiting nowThis study tests whether a single infusion of a patient's own genetically engineered immune cells (E7 TCR-T cells) can shrink or eliminate HPV-related cancers before the patient receives standard treatment like chemo-radiation or surgery. The trial enrolls 15 adults with advanced…
Phase: PHASE1, PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a Chemo-Immuno combo boost cancer fight before surgery?
Disease control Recruiting nowThis phase 2 trial tests whether combining the chemotherapy 5-azacytidine with the immunotherapy nivolumab can make HPV-related head and neck cancer more responsive to treatment. About 50 people with resectable tumors will receive one or both drugs before surgery. The goal is to …
Phase: PHASE2 • Sponsor: Barbara Burtness • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New radiation drug targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a radioactive drug that seeks out and delivers radiation directly to cancer cells with a specific protein (somatostatin receptor). It is for adults with advanced lung, kidney, head and neck, digestive tract, or adrenal gland tumors that cannot be remo…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Donated aortic patches could fix windpipe damage in small trial
Disease control Recruiting nowThis study tests whether using cryopreserved aortic patches (donated tissue) can safely repair defects in the windpipe or bronchial tubes. Ten people with severe tracheal narrowing or deformities will receive this surgical patch. The main goal is to see if it reduces death and co…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Supercharged immune cells take on HPV cancers
Disease control Recruiting nowThis study tests a new immunotherapy for people with advanced HPV-related cancers, such as cervical, throat, anal, and penile cancers. Participants receive specially engineered immune cells designed to attack cancer cells carrying the HPV16 virus. The goal is to see if this treat…
Phase: PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
One surgery to fix tooth-related sinusitis? new trial aims to find out.
Disease control Recruiting nowThis study tests a single surgery that combines sinus endoscopy with oral surgery to treat sinusitis caused by dental issues. 36 adults who haven't improved with standard dental or medical care will receive this procedure. The goal is to see if this combined approach works better…
Phase: NA • Sponsor: Qassim University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New risk model may let some NPC patients avoid unnecessary chemo
Disease control Recruiting nowThis study tests a personalized approach for people with advanced nasopharyngeal cancer. After standard chemoradiation, some patients get extra therapy to prevent the cancer from returning. But this extra therapy can cause side effects. The trial uses a new risk model (RAIRI) to …
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New combo injection targets Hard-to-Treat head and neck tumors
Disease control Recruiting nowThis early-phase trial is testing a new approach for people with head and neck cancer that has returned or spread after standard chemotherapy. The treatment combines a gene therapy injection (EDS01) given directly into a tumor with an immunotherapy drug (toripalimab) given throug…
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Smarter radiation: could less be more for throat cancer patients?
Disease control Recruiting nowThis study tests whether giving less radiation to healthy lymph nodes can reduce side effects for people with oropharynx cancer. The approach uses a computer model to personalize which lymph nodes need treatment. The trial will enroll 120 patients and track if cancer returns in u…
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could skipping radiation to the tongue reduce side effects without raising cancer risk?
Disease control Recruiting nowThis study is for people who had surgery for oral tongue cancer and need radiation to prevent recurrence. Instead of radiating the whole mouth, doctors will only target the neck lymph nodes, sparing the tongue. The goal is to see if this reduces severe mouth sores while keeping t…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for rare cancer: targeted drug afatinib tested in fanconi anemia patients
Disease control Recruiting nowThis study tests a drug called afatinib in 25 adults with Fanconi anemia who have advanced head and neck cancer that cannot be removed by surgery. Afatinib is a pill that blocks a protein helping cancer grow. The goal is to see if it can shrink tumors and control the disease. Res…
Phase: PHASE1, PHASE2 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug cocktail targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new antibody called HMBD-001 combined with two existing cancer drugs (cetuximab and docetaxel) in people with advanced squamous cell cancers of the lung, head and neck, esophagus, cervix, or skin. The goal is to see if the combination is safe and can shrink tum…
Phase: PHASE1, PHASE2 • Sponsor: Hummingbird Bioscience • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Low-Dose radiation plus immunotherapy shows promise for Tough-to-Treat nasopharyngeal cancer
Disease control Recruiting nowThis Phase 2 trial is testing whether adding low-dose radiotherapy to a standard chemotherapy regimen (gemcitabine and cisplatin) plus the immunotherapy drug toripalimab can help control recurrent or metastatic nasopharyngeal carcinoma. About 55 adults aged 18-65 with confirmed n…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New study aims to cut side effects in throat cancer treatment
Disease control Recruiting nowThis phase II trial is testing whether giving radiation only to the side of the neck where the cancer is found can reduce dry mouth and other side effects in people with HPV-positive oropharynx cancer. About 22 participants will receive radiation (with or without chemotherapy) to…
Phase: PHASE2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could less radiation be just as effective for HPV+ throat cancer?
Disease control Recruiting nowThis study is testing whether a lower dose of radiation (30 Gy) can safely treat HPV-positive oropharyngeal cancer while reducing side effects. About 31 adults with this type of throat cancer will receive the reduced radiation along with standard chemotherapy. The main goal is to…
Phase: PHASE2 • Sponsor: Sara Medek • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New biologics offer hope for severe nasal polyps sufferers
Disease control Recruiting nowThis study follows 900 adults with severe chronic sinusitis and nasal polyps who are taking biologic drugs. Researchers will track how these treatments affect quality of life, symptoms, and side effects over 5 years. The goal is to see which patients benefit most based on their h…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug combo aims to keep High-Risk nasopharyngeal cancer at bay
Disease control Recruiting nowThis phase 3 trial tests whether adding toripalimab (an immunotherapy) to capecitabine (a chemotherapy pill) as maintenance therapy works better than capecitabine alone for people with high-risk nasopharyngeal carcinoma. The study enrolls 264 adults aged 18-70 who have completed …
Phase: PHASE3 • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for kids with tough cancers: targeted drug trial launches
Disease control Recruiting nowThis study tests a new drug called Becotatug Vedotin in children aged 2 to 18 with certain solid tumors that have come back or spread. The drug targets a protein called EGFR found on many cancer cells. The main goal is to see if the drug is safe and to find the best dose, while a…
Phase: PHASE1 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a common numbing drug help fight throat cancer?
Disease control Recruiting nowThis early-stage trial is testing whether injecting the local anesthetic lidocaine into HPV-related throat tumors before robotic surgery is safe and might help destroy more cancer cells. About 30 adults with HPV-positive oropharyngeal cancer will receive the injection during a ro…
Phase: PHASE1 • Sponsor: Ryan Carey • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New triple therapy aims to control advanced nose cancer
Disease control Recruiting nowThis study tests a combination of three drugs—an EGFR antibody, a PD-1 inhibitor, and chemotherapy—in people whose nasopharyngeal cancer has returned or spread. The goal is to see if this mix can slow or stop the cancer from growing. About 148 adults aged 18-75 who have not had p…
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for tough nasopharyngeal cancer: Triple-Drug combo trial launches
Disease control Recruiting nowThis study tests a combination of three drugs (sintilimab, anlotinib, and chemotherapy) in 33 adults with recurrent or metastatic nasopharyngeal cancer that has not responded to prior immunotherapy. The goal is to see if this combo can shrink tumors or control the disease. Partic…
Phase: PHASE2 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can better nutrition improve outcomes for head and neck cancer patients?
Disease control Recruiting nowThis phase 3 trial tests whether a structured nutrition plan (including supplements, feeding tubes, or IV nutrition) helps malnourished patients with advanced nasopharyngeal carcinoma maintain weight and improve their prognosis. About 266 participants will receive either standard…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Nasal spray vaccine plus immunotherapy shows promise in early throat cancer trial
Disease control Recruiting nowThis early-phase trial is testing whether a nasal spray vaccine (WSK-IM05) combined with an immunotherapy drug (tislelizumab) can safely shrink HPV-positive throat tumors before surgery. Nine adults with newly diagnosed, resectable HPV-positive oropharyngeal cancer will receive t…
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could less radiation be enough for HPV throat cancer?
Disease control Recruiting nowThis study is testing whether giving lower doses of radiation over a shorter time, along with standard chemotherapy, works as well as the usual higher radiation doses for people with HPV-positive throat cancer. About 74 participants will receive chemoradiation with drugs like cis…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Radiation and immunotherapy combo shows promise for advanced nasopharyngeal cancer
Disease control Recruiting nowThis phase II trial is testing whether combining two types of radiation (SBRT and low-dose radiation) with an immunotherapy drug (toripalimab) and chemotherapy can help control recurrent or metastatic nasopharyngeal carcinoma. The study will enroll 148 participants who have not r…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Pill combo offers new hope for rural head and neck cancer patients
Disease control Recruiting nowThis study is testing whether taking three oral chemotherapy drugs together is safe and practical for patients with head and neck cancer that has returned or spread. The trial focuses on people living in rural Midwest areas, making it easier for them to participate from home. The…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug combo could shrink tumors and reduce radiation side effects in nose cancer
Disease control Recruiting nowThis phase 3 trial tests whether adding an immunotherapy drug (cadonilimab) and low-dose radiation to standard chemotherapy can improve outcomes for people with advanced nasopharyngeal cancer. About 380 participants will be randomly assigned to receive either the new combination …
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Immunotherapy combo aims to beat back recurrent nasopharyngeal cancer
Disease control Recruiting nowThis phase 3 trial tests whether adding an immunotherapy drug called toripalimab to standard chemoradiotherapy helps people with recurrent nasopharyngeal carcinoma live longer. About 212 participants whose cancer has returned after prior treatment and who cannot have surgery will…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New chemo approach may spare sinus cancer patients from major surgery
Disease control Recruiting nowThis study is for people with a rare sinus cancer called sinonasal adenoid cystic carcinoma. The treatment delivers high-dose chemotherapy directly to the tumor through a small tube in an artery, aiming to shrink it as much as possible. After three sessions, doctors check if the …
Phase: PHASE2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New study tests gum surgery to speed up braces and improve results
Disease control Recruiting nowThis study compares two flapless surgical techniques used alongside braces to see which better improves gum and bone changes. Forty adults with mild to moderate crowding will receive either a soft tissue graft or a bone graft during their orthodontic treatment. Researchers will m…
Phase: NA • Sponsor: Universidad Complutense de Madrid • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could a 3-Week radiation course replace 6 weeks for head and neck cancer?
Disease control Recruiting nowThis study compares a standard 6-week radiation course after surgery to a shorter 3-week course for people with head and neck cancer. The goal is to see if the shorter schedule works just as well at preventing cancer from coming back. About 369 participants will be randomly assig…
Phase: PHASE2, PHASE3 • Sponsor: All India Institute of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Immunotherapy boost may improve outcomes in returning throat cancer
Disease control Recruiting nowThis phase 3 trial tests whether adding an immunotherapy drug (PD-1 antibody) to standard chemoradiotherapy helps people with recurrent nasopharyngeal carcinoma live longer. About 212 participants whose cancer has returned after prior treatment and cannot be surgically removed wi…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New surgery technique could improve survival in recurrent throat cancer
Disease control Recruiting nowThis study compares two surgical techniques for treating nasopharyngeal cancer that has come back after radiation. 500 participants will be randomly assigned to receive either low-temperature plasma ablation or high-frequency electrocautery. The goal is to see which method leads …
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Oral cancer patients may avoid unnecessary radiation to the neck
Disease control Recruiting nowThis study tests whether it is safe to skip radiation to the lymph nodes in the neck after surgery for early-stage oral cancer. About 396 adults aged 18-70 with certain high-risk features will be randomly assigned to receive or not receive this radiation. The goal is to see if sk…
Phase: PHASE2, PHASE3 • Sponsor: All India Institute of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could less radiation be enough for HPV throat cancer?
Disease control Recruiting nowThis study is testing whether a reduced dose of radiation can safely treat HPV-positive oropharyngeal (throat) cancer. About 111 patients will receive a lower total radiation dose than usual, with some also getting chemotherapy if needed. The goal is to see if this approach keeps…
Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could less radiation be safer? new trial aims to cut side effects after head and neck cancer surgery
Disease control Recruiting nowThis phase II trial tests whether a personalized, reduced-volume radiation plan can safely lower side effects after surgery for head and neck cancer. About 50 patients will receive radiation only to high-risk areas, skipping some traditionally treated zones. The goal is to see if…
Phase: PHASE2 • Sponsor: Olgun Elicin • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo therapy aims to halt spread of nasopharyngeal cancer
Disease control Recruiting nowThis phase 3 trial tests whether adding a precise form of radiation (SBRT) to the immunotherapy drug camrelizumab helps control cancer better than camrelizumab alone in people with nasopharyngeal cancer that has spread to a few spots (oligometastatic). About 188 adults whose prim…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Could less radiation be enough for HPV throat cancer?
Disease control Recruiting nowThis study is testing whether giving less radiation, based on a patient's HPV type and levels of HPV DNA in the blood, can control throat cancer as well as standard higher doses. About 250 adults with favorable-prognosis oropharyngeal cancer will receive 70, 60, or 50 gray of rad…
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo aims to shrink radiation damage in head and neck cancer
Disease control Recruiting nowThis study tests two ideas at once: adding a drug called ATRA (Vesanoid) to standard treatment, and using a smaller radiation area that targets the tumor more precisely. It includes 460 adults with certain types of head and neck cancer that haven't spread across the midline. The …
Phase: PHASE3 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Immunotherapy cocktail takes on tough throat cancer
Disease control Recruiting nowThis study tests whether adding an immunotherapy drug (penpulimab) to standard chemotherapy and radiation, followed by maintenance immunotherapy, works better than the usual maintenance drug capecitabine for people with high-risk nasopharyngeal cancer. About 142 participants with…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Nerve surgery offers new hope for silent breathing struggle
Disease control Recruiting nowThis study looks at a surgery called selective laryngeal reinnervation for people whose vocal cords are paralyzed on both sides, making it hard to breathe. Researchers will track 15 adults aged 18 to 70 to see if the surgery improves breathing symptoms and lung function. The goal…
Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could less radiation be just as good for HPV throat cancer?
Disease control Recruiting nowThis study is testing whether a much lower dose of radiation (30 Gy) combined with standard chemotherapy can control HPV-positive throat cancer as well as the usual high dose (70 Gy). The goal is to reduce side effects from radiation while still keeping the cancer from coming bac…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Nanoengineered patches and injectables aim to fight cancer locally
Disease control Recruiting nowThis study tests three new ways to deliver the chemotherapy drug cisplatin directly to tumors in the mouth or lungs. The goal is to kill cancer cells while reducing side effects on the rest of the body. About 40 adults with early-stage oral or lung cancer will receive the treatme…
Phase: PHASE2, PHASE3 • Sponsor: Privo Technologies • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could less radiation be enough for HPV throat cancer? new trial aims to find out.
Disease control Recruiting nowThis study is testing whether people with early-stage HPV-positive throat cancer can be treated with radiation alone at a lower dose, instead of the usual full-dose radiation plus chemotherapy. The goal is to see if this gentler approach can keep the cancer from coming back while…
Phase: NA • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Could less radiation be better for head and neck cancer?
Disease control Recruiting nowThis study is for people with head and neck cancer. It compares two types of radiation therapy: one that treats only the cancer and nearby lymph nodes (INRT) and one that treats a larger area (ENI). The goal is to see if the smaller treatment area works just as well and causes fe…
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for hearing loss? drug targets inner ear inflammation
Disease control Recruiting nowThis phase 2 trial tests whether anakinra (Kineret), an anti-inflammatory drug, can improve hearing in people with Meniere's disease or autoimmune inner ear disease who cannot take steroids. About 57 participants will receive daily injections of anakinra or a placebo for 42 days,…
Phase: PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New combo therapy aims to keep High-Risk nasopharyngeal cancer at bay
Disease control Recruiting nowThis phase 2 trial is testing whether a year-long combination of tislelizumab (an immunotherapy) and low-dose capecitabine (a chemotherapy pill) can prevent cancer relapse in 53 patients with high-risk nasopharyngeal carcinoma. Participants have already received standard chemothe…
Phase: PHASE2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Blood test may help some throat cancer patients skip or shorten radiation
Disease control Recruiting nowThis study is testing whether a blood test that detects HPV DNA can help doctors decide who needs radiation after surgery for HPV-related oropharynx cancer. In one group, patients with no detectable HPV DNA after surgery will be watched closely and only get radiation if the test …
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could a food preservative help fight oral cancer?
Disease control Recruiting nowThis study tests whether nisin, a natural preservative found in some foods, can safely change the bacteria in the mouths of people with oral cavity squamous cell carcinoma. About 40 patients will take nisin before and after their standard surgery. The goal is to find a safe dose …
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could immunotherapy spare throat cancer patients from losing their voice?
Disease control Recruiting nowThis phase 2 trial is testing whether adding the immunotherapy drug toripalimab to standard chemotherapy can help people with advanced laryngeal or hypopharyngeal cancer avoid having their voice box removed. The study will enroll 87 adults whose cancer has not been treated before…
Phase: PHASE2 • Sponsor: Matthew Spector • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for hard-to-treat nose and throat cancer: targeted drug combo shows promise
Disease control Recruiting nowThis study tests a drug called becotatug vedotin in people with advanced nasopharyngeal cancer whose tumors didn't shrink enough after standard chemo-immunotherapy. About 59 adults will receive the drug during and after radiation therapy. The goal is to see if this approach can p…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could less radiation be just as good for nasopharyngeal cancer?
Disease control Recruiting nowThis phase 3 trial is testing whether giving a lower dose of radiation to low-risk areas around the main tumor works as well as the standard higher dose for nasopharyngeal cancer. The study plans to enroll 700 people aged 18-70 with newly diagnosed, non-spreading cancer. The goal…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Immune cell army targets Hard-to-Treat throat cancer
Disease control Recruiting nowThis early-phase study tests whether specially engineered immune cells (CAR-T and TCR-T) can safely fight Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma that has returned or not responded to treatment. About 24 adults will receive one of two types of cell therapy, wit…
Phase: EARLY_PHASE1 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a herbal formula restore hearing? new trial investigates
Disease control Recruiting nowThis study tests whether Yiyuancong, a traditional Chinese medicine made from food-like ingredients, can help people with sudden hearing loss. About 128 adults aged 18-60 will take the formula for 1-2 months, and their hearing will be measured with standard tests. The goal is to …
Phase: NA • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Blood test may allow safer, Lower-Dose radiation for throat cancer patients
Disease control Recruiting nowThis study tests whether a blood test that detects HPV DNA can guide doctors to safely use a lower dose of radiation for people with HPV-related throat cancer. About 45 adults with early-stage HPV-positive oropharyngeal cancer will receive radiation and chemotherapy. The goal is …
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Hope for takayasu patients: study tests stopping biologic drugs after years of remission
Disease control Recruiting nowThis study looks at whether people with Takayasu arteritis, a rare blood vessel disease, can safely stop taking biologic medications after being in remission for a long time. About 40 participants who have been on biologics for at least 3 years and have no active disease will slo…
Phase: NA • Sponsor: Marmara University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could less radiation be enough for HPV throat cancer?
Disease control Recruiting nowThis study is for people with HPV-positive oropharyngeal (throat) cancer who have had surgery. Researchers want to see if giving a lower dose of radiation to a smaller area (just the neck, not the original tumor site) works as well as the standard higher dose. The goal is to redu…
Phase: NA • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New combo therapy aims to tackle rare nasal cancer
Disease control Recruiting nowThis phase 2 trial tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy can shrink advanced squamous cell cancers of the nasal cavity and sinuses better than chemotherapy alone. About 35 adults with newly diagnosed, untreated stage II to IVb disease …
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Immunotherapy combo trial aims to boost survival in head and neck cancer
Disease control Recruiting nowThis phase II trial is testing whether adding the immunotherapy drug Toripalimab to different platinum-based chemotherapy regimens, followed by standard chemoradiotherapy, can improve outcomes for people with locally advanced nasopharyngeal cancer. About 243 participants will be …
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New combo therapy aims to improve survival in advanced nose cancer
Disease control Recruiting nowThis phase 3 trial tests whether a new drug (Becotatug vedotin) plus immunotherapy (sintilimab) and standard chemoradiation works better than current standard treatment for high-risk nasopharyngeal cancer. About 266 adults with advanced but non-spread cancer will be randomly assi…
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could less radiation be better for head and neck cancer patients?
Disease control Recruiting nowThis study tests whether giving less radiation after surgery for certain head and neck cancers can reduce long-term side effects, like trouble swallowing, without allowing the cancer to come back. About 508 adults who have had surgery and need standard post-op radiation will be r…
Phase: PHASE2, PHASE3 • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can a daily supplement shorten your cold? new study in seniors aims to find out
Disease control Recruiting nowThis study is testing whether a dietary supplement called IDP (Immune Defense Protein) can reduce the length and severity of cold and flu symptoms in people aged 60 and older. About 300 participants will take either a low or high dose of IDP or a placebo daily during cold and flu…
Phase: NA • Sponsor: Quantec Ltd • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Proton beam takes aim at returning throat cancer
Disease control Recruiting nowThis study is testing a precise type of radiation called proton therapy for people whose nasopharyngeal cancer has come back. The goal is to see if it can control the cancer while causing fewer severe side effects than standard treatments. About 52 adults with recurrent, non-spre…
Phase: NA • Sponsor: Guangzhou Concord Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Balance-Restoring implant shows promise for dizziness sufferers
Disease control Recruiting nowThis study follows 15 adults (ages 22–90) with severe, long-term balance disorders caused by inner ear damage. Participants have already received a vestibular implant, a device that electrically stimulates the balance nerve to help restore steadiness and clear vision during movem…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Personalized vaccine takes on head and neck cancer in early trial
Disease control Recruiting nowThis early-phase trial tests a personalized vaccine made from a patient's own tumor cells, given alone or with the immunotherapy drug pembrolizumab, for people with head and neck cancer that has returned or spread. The main goals are to check safety, find the best dose, and see i…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Could less radiation be just as good for some throat cancers?
Disease control Recruiting nowThis phase 3 trial is testing whether a lower dose of radiation, combined with chemotherapy and an immunotherapy drug called Camrelizumab, can control stage III nasopharyngeal cancer as well as the standard higher dose. About 593 patients whose tumors respond well to initial trea…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Can immunotherapy let doctors dial down cancer treatment without sacrificing cures?
Disease control Recruiting nowThis phase II trial is testing whether giving the immunotherapy drug cemiplimab (sometimes with chemotherapy) before standard treatment can shrink tumors enough to allow less intense local therapy, such as reduced radiation or surgery. The goal is to maintain high cure rates whil…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Less radiation, same control? new trial aims to boost quality of life for throat cancer patients
Disease control Recruiting nowThis study tests whether a shorter, lower-dose course of radiation after robotic surgery can improve quality of life for people with HPV-related throat cancer. About 42 adults who have had robotic surgery will receive a reduced radiation schedule. The goal is to see if this appro…
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New cocktail of drugs shows promise for Tough-to-Treat throat cancer
Disease control Recruiting nowThis phase II trial is testing whether adding an immunotherapy drug (envafolimab) and a blood-vessel blocker (endostatin) to standard chemoradiotherapy can improve outcomes for 30 people with locally advanced nasopharyngeal carcinoma. The main goal is to see how many patients hav…
Phase: PHASE2 • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug duo offers hope for hard-to-treat head and neck cancer
Disease control Recruiting nowThis study tests whether combining two drugs, sacituzumab govitecan and cetuximab, can shrink or control advanced head and neck cancer that has grown after initial therapy. About 40 adults whose cancer has spread or returned will receive the combination. The goal is to see how ma…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can a common cholesterol drug boost immunotherapy against head and neck cancer?
Disease control Recruiting nowThis phase II trial tests whether adding lovastatin, a common cholesterol-lowering drug, to the immunotherapy pembrolizumab can help shrink tumors in people with head and neck cancer that has returned or spread. The study will enroll 28 adults whose tumors express PD-L1. Research…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can common drugs stop radiation damage? new trial aims to prevent lymphedema
Disease control Recruiting nowThis phase 2 trial tests whether pravastatin (a cholesterol drug) or a combination of pentoxifylline and vitamin E can prevent lymphedema and fibrosis (swelling and scarring) caused by radiation therapy in head and neck cancer patients. About 295 adults with oropharyngeal cancer …
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Radiation after surgery may keep tongue cancer at bay for High-Risk patients
Disease control Recruiting nowThis study looks at whether giving radiation therapy after surgery can delay the return of early-stage tongue cancer in patients who have certain risk factors. About 190 adults aged 18 to 70 will be randomly assigned to either receive radiation or just be monitored. The goal is t…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Robotic scalpel takes on head and neck cancer
Disease control Recruiting nowThis study is testing a less invasive robotic surgery called TORS for people with head and neck tumors. The goal is to see if it is safe and effective, with fewer side effects and faster recovery than traditional surgery. Up to 600 participants will be enrolled, and their outcome…
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Immunotherapy plus chemo shows promise in shrinking HPV throat tumors before surgery
Disease control Recruiting nowThis Phase 2 trial is testing whether giving the immunotherapy drug toripalimab along with standard chemotherapy before surgery or radiation can shrink HPV16-positive oropharyngeal (throat) tumors by at least 50%. The study enrolls 30 patients with advanced but localized disease.…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Blood test may allow safer radiation for head and neck cancer
Disease control Recruiting nowThis study is testing whether a lower dose of radiation, guided by a blood test that detects HPV DNA from tumors, can safely treat head and neck cancer. About 90 adults with squamous cell carcinoma of the oropharynx will receive reduced radiation to the neck. The goal is to see i…
Phase: PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Tailored therapy aims to cut side effects for throat cancer patients
Disease control Recruiting nowThis study tests whether giving patients with a specific type of throat cancer (p16+ oropharyngeal cancer) a personalized, less intense treatment can keep cancer from coming back while reducing side effects. About 150 adults with early-stage disease will either have surgery follo…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New vaccine aims to train immune system against HPV cancers
Disease control Recruiting nowThis study tests a new vaccine called Lenti-HPV-07 in 72 people with HPV-related throat or cervical cancer. The goal is to see if it is safe and can boost the immune system to fight the cancer. Participants receive the vaccine and are monitored for up to one year.
Phase: PHASE1, PHASE2 • Sponsor: Theravectys S.A. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Second radiation may boost survival in returning throat cancer
Disease control Recruiting nowThis study is for people whose nasopharyngeal cancer has come back after initial treatment and cannot be removed by surgery. Participants first receive a combination of chemotherapy and an immunotherapy drug (PD-1 inhibitor). Those whose tumors shrink or disappear are then random…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New combo therapy aims to stop oral cancer from coming back
Disease control Recruiting nowThis phase 3 trial tests whether adding the immunotherapy drug sintilimab to chemotherapy before and after surgery can improve outcomes for people with advanced oral cancer. About 104 participants will be randomly assigned to receive either the combination therapy or standard sur…
Phase: PHASE3 • Sponsor: Qunxing Li,MD • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could less be more? Radiation-Only trial for nasopharyngeal cancer
Disease control Recruiting nowThis study looks at whether using only targeted radiation (IMRT) can effectively control stage IB nasopharyngeal cancer in patients without high-risk features. About 169 adults aged 18-70 with newly diagnosed, early-stage disease will be followed to see how many remain cancer-fre…
Sponsor: Qiaojuan Guo • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug BL-B01D1 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called BL-B01D1 in people with advanced lung cancer or other solid tumors that have spread or cannot be removed. The main goals are to check the drug's safety, find the best dose, and see if it helps shrink tumors. About 470 adults will tak…
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a drug combo save nerves in ear cancer surgery?
Disease control Recruiting nowThis phase 2 trial is testing whether giving the immunotherapy drug tislelizumab along with chemotherapy before surgery can shrink advanced squamous cell carcinoma of the ear canal. The goal is to make surgery easier and safer, especially to protect important nerves near the ear.…
Phase: PHASE2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New immune combo targets hard-to-treat nose and throat cancer
Disease control Recruiting nowThis study tests a combination of two immune-boosting drugs (iparomlimab and tuvonralimab) plus a targeted antibody (nimotuzumab) in people with advanced nasopharyngeal cancer that got worse after standard first treatment. About 41 adults aged 18-70 will receive the therapy to se…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Promising cocktail aims to shrink tonsil tumors before surgery
Disease control Recruiting nowThis pilot study is testing whether a combination of two targeted drugs (nimotuzumab and toripalimab) plus standard chemotherapy can shrink locally advanced tonsillar cancer before surgery. Ten adults with resectable tumors will receive the treatment for 2-4 cycles, then have sur…
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Absorbable 3D-Printed splint could save kids with rare breathing disorder
Disease control Recruiting nowThis study tests a custom 3D-printed splint that holds open a child's collapsing airway. The splint is made of a material that the body absorbs over about five years. The trial includes 35 children with severe tracheobronchomalacia who need breathing support. Researchers will che…
Phase: NA • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New smart drug TQB6411 targets two cancer proteins in early human trial
Disease control Recruiting nowThis Phase 1 trial tests TQB6411, an antibody-drug conjugate designed to bind to EGFR and c-Met proteins on tumor cells, blocking their growth signals and releasing a toxin to kill the cells. The study will enroll 216 adults with advanced malignant tumors to find the safest dose …
Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug cocktail aims to outdo chemo for tough throat cancer
Disease control Recruiting nowThis Phase 3 trial tests whether combining two drugs, MRG003 and pucotenlimab, works better than standard chemotherapy for people with nasopharyngeal cancer that has returned or spread. About 446 participants will be randomly assigned to receive either the new combo or one of thr…
Phase: PHASE3 • Sponsor: Shanghai Miracogen Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Proton beam vs. standard radiation: which is safer for advanced throat cancer?
Disease control Recruiting nowThis study compares two radiation methods—proton therapy and standard photon therapy—for people with advanced nasopharyngeal cancer. All 300 participants will receive chemotherapy and immunotherapy alongside radiation. The goal is to see which approach causes fewer severe side ef…
Phase: PHASE3 • Sponsor: Man Hu • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could a diabetes drug and a blood pressure pill shield vasculitis patients from heart attacks?
Disease control Recruiting nowThis study tests whether two drugs—bosentan and dapagliflozin—can improve blood vessel function in people with large vessel vasculitis, a condition that damages arteries and raises the risk of heart attacks and strokes. Sixty adults with stable disease will take both drugs for 6 …
Phase: PHASE2 • Sponsor: University of Edinburgh • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Inner ear implant aims to steady older adults with chronic dizziness
Disease control Recruiting nowThis study tests a vestibular implant in 15 older adults (ages 65-90) with chronic balance issues due to bilateral vestibular hypofunction. The implant electrically stimulates the inner ear to improve balance and vision. Researchers will measure changes in gait and eye reflexes o…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Inner ear implant aims to restore balance in dizzy patients
Disease control Recruiting nowThis study tests a vestibular implant, a device surgically placed in the inner ear to electrically stimulate balance nerves. It aims to improve balance, posture, and vision in up to 8 adults with bilateral vestibular hypofunction, a condition causing chronic dizziness and instabi…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could less radiation be enough? new trial for advanced throat cancer
Disease control Recruiting nowThis study is for people with advanced nasopharyngeal cancer (a type of throat cancer) whose tumors shrank significantly after initial chemotherapy and immunotherapy. It compares a lower dose of radiation therapy to the standard dose, both given with additional chemo and immunoth…
Phase: PHASE3 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could less radiation be better for some head and neck cancers?
Disease control Recruiting nowThis study compares a lower dose of radiation (40.2Gy) to the standard dose (49.2Gy) for people with stage II nasopharyngeal cancer that responds well to chemotherapy. All participants also receive immunotherapy. The goal is to see if the lower dose can control the cancer just as…
Phase: PHASE3 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Promising trial aims to spare throat cancer patients from unnecessary radiation
Disease control Recruiting nowThis study tests whether people with HPV-positive throat cancer can safely receive a lower dose of radiation if their tumor shrinks quickly during early treatment. About 120 participants will be monitored for 2 years to see if the reduced treatment still prevents cancer from comi…
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for advanced throat cancer: study tests smarter treatment for spread to neck nodes
Disease control Recruiting nowThis study is for people with hypopharyngeal cancer that has spread to neck lymph nodes. It compares a new treatment plan to standard care to see if it can delay cancer growth or improve survival. About 111 adults aged 18-75 with good overall health can join.
Phase: NA • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New device could make ear reconstruction faster and more Natural-Looking for kids
Disease control Recruiting nowThis study tests a new medical device that helps surgeons shape cartilage into a more natural-looking ear for children and young adults with missing or deformed ears due to birth defects, injuries, or cancer surgery. About 30 participants aged 5-20 will be enrolled. The goal is t…
Phase: NA • Sponsor: Nemours Children's Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could less radiation be just as effective for neck cancer?
Disease control Recruiting nowThis study tests whether giving radiation only to the parts of the neck where cancer has spread works as well as treating the entire neck in people with nasopharyngeal carcinoma. About 462 adults with stage I–III disease will be randomly assigned to receive either standard or ind…
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug combo aims to shrink throat tumors before surgery
Disease control Recruiting nowThis study tests whether adding the drug finotonlimab to standard chemotherapy before surgery can improve outcomes for people with advanced hypopharyngeal cancer (a type of throat cancer). About 116 adults who have not had prior treatment will be randomly assigned to receive eith…
Phase: PHASE2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Gene therapy retreatment aims to cut surgeries for rare throat tumor condition
Disease control Recruiting nowThis study tests a gene therapy called Zopapogene imadenovec (Zopa) in 30 adults with recurrent respiratory papillomatosis (RRP), a condition causing non-cancerous throat tumors that often require repeated surgeries. One group will check how the virus used in the therapy leaves t…
Phase: PHASE4 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could less radiation be better? new trial aims to reduce side effects for advanced nose cancer patients
Disease control Recruiting nowThis phase 3 trial tests whether giving less radiation to low-risk areas (reduced-target) is as effective as standard full-target radiation for patients with metastatic nasopharyngeal carcinoma who have already responded to chemotherapy and immunotherapy. The study involves 166 a…
Phase: PHASE3 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New program aims to speed up radiation for head and neck cancer patients
Disease control Recruiting nowThis trial tests a program called ENDURE that helps head and neck cancer patients start radiation therapy within 6 weeks after surgery. The program provides education, social support, and better coordination among doctors. Researchers will compare it to usual care in 532 adults w…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New pill shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental drug called VMD-928, taken as a pill, either alone or with another cancer drug (pembrolizumab). It is for adults with advanced solid tumors or lymphoma that have not responded to or are no longer controlled by available treatments. The goal is to …
Phase: PHASE1, PHASE2 • Sponsor: VM Oncology, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New hope for recurrent throat cancer: Radiation-Immunotherapy combo shows promise
Disease control Recruiting nowThis phase II trial tests a new approach for recurrent nasopharyngeal carcinoma (a type of throat cancer) that has come back after initial treatment and cannot be removed by surgery. The treatment combines a special radiation schedule (low and high doses) with an immunotherapy dr…
Phase: PHASE2 • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Nasal polyp patients may finally ditch pricey biologics
Disease control Recruiting nowThis study looks at whether people with severe nasal polyps who have been symptom-free for at least a year on biologic drugs like Dupixent or Nucala can safely stop taking them. 66 participants will either stop their medication or continue as usual, and researchers will track if …
Phase: PHASE4 • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New radiation combo for nasal cancer: proton vs. photon in major trial
Disease control Recruiting nowThis phase 3 trial is testing whether proton radiation therapy plus carbon ion therapy works as well as standard photon radiation plus carbon ion for newly diagnosed nasopharyngeal carcinoma. About 470 participants will be randomly assigned to one of the two radiation types. The …
Phase: PHASE3 • Sponsor: Lin Kong, MD • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New hope for advanced nose and throat cancer with combo therapy
Disease control Recruiting nowThis study tests a new drug (YL201) combined with an immunotherapy (toripalimab), with or without chemotherapy (cisplatin), in people whose nasopharyngeal cancer has come back or spread. The goal is to see if the combination is safe and helps control the cancer. About 202 adults …
Phase: PHASE1, PHASE2 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New vaccine aims to train immune system against HPV throat cancer
Disease control Recruiting nowThis study tests a vaccine designed to help the immune system fight HPV-positive throat cancer. It is for patients who have completed surgery or chemoradiation and show no signs of cancer remaining. The trial will enroll 24 adults to find the safest and most effective dose by mea…
Phase: PHASE1, PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New surgical combo aims to tame stubborn nasal polyps
Disease control Recruiting nowThis study looks at whether adding a procedure that removes lymphoid tissue in the back of the nose to standard sinus surgery can better control inflammation in people with nasal polyps. Thirty-two adults with nasal polyps will be randomly assigned to get either standard surgery …
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New combo therapy aims to outsmart nasopharyngeal cancer
Disease control Recruiting nowThis phase 3 trial tests whether adding immunotherapy to standard treatment can improve outcomes for people with advanced nasopharyngeal cancer. About 802 participants will be split into low-risk and high-risk groups to see if personalized treatment can reduce side effects and pr…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New hope for Hard-to-Treat nasopharyngeal cancer: targeted drug HLX43 enters phase 2 trial
Disease control Recruiting nowThis phase 2 trial tests HLX43, a drug that targets a protein called PD-L1 on cancer cells and delivers a toxin to kill them. It is for people with recurrent or metastatic nasopharyngeal carcinoma who have failed or cannot tolerate second-line therapy. About 70 participants will …
Phase: PHASE2 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Smarter radiation for head & neck cancer: Biopsy-Guided treatment may spare patients from dry mouth
Disease control Recruiting nowThis phase 3 trial tests whether using a sentinel lymph node biopsy to guide radiation can safely reduce the amount of neck radiation in people with certain head and neck cancers. The goal is to lower long-term side effects like severe dry mouth while still controlling the cancer…
Phase: PHASE3 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could delaying radiation be just as good for advanced nasopharyngeal cancer?
Disease control Recruiting nowThis phase 3 trial is testing whether giving radiation only when needed (salvage therapy) works as well as giving it right away after immunotherapy and chemotherapy in people with nasopharyngeal cancer that has spread. The goal is to see if delaying radiation can reduce side effe…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for VHL patients: belzutifan trial targets rare tumor disorder
Disease control Recruiting nowThis study tests the drug belzutifan in 100 people with von Hippel-Lindau (VHL) syndrome, a genetic condition that causes tumors in various organs. Researchers will track how well the drug shrinks tumors and how long it takes for the disease to progress, while also monitoring sid…
Phase: PHASE2 • Sponsor: José Claudio Casali da Rocha • Aim: Disease control
Last updated Jun 26, 2026 15:43 UTC
-
New study aims to cut antibiotic overuse in children with ear infections
Disease control Recruiting nowThis study looks at two methods to help doctors prescribe fewer antibiotics for children with ear infections when they aren't needed. One method uses changes to electronic health records and feedback reports for doctors. The other adds a shared decision-making tool that involves …
Phase: NA • Sponsor: Intermountain Health Care, Inc. • Aim: Disease control
Last updated Jun 26, 2026 13:12 UTC
-
New imaging tool could make mouth biopsies more accurate
Diagnosis Recruiting nowThis study tests a new imaging device called the Active Biopsy Guidance System to help doctors decide when and where to take tissue samples (biopsies) from mouth lesions. About 90 adults with suspicious mouth spots or a history of oral cancer will participate. The goal is to see …
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
New laser camera could revolutionize oral cancer diagnosis
Diagnosis Recruiting nowThis study is testing a special camera that uses a laser to take microscopic pictures of suspicious spots inside the mouth. The goal is to see if these images can help doctors diagnose oral cancers and guide surgery. About 140 people with oral cancer will have their lesions image…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
Infrared eye on ear infections: new device aims to see fluid that white light misses
Diagnosis Recruiting nowThis trial tests whether a short wave infrared (SWIR) otoscope can more accurately diagnose middle ear fluid in children than a standard white light otoscope. About 100 children scheduled for ear tube surgery will have images taken with both devices. The presence or absence of fl…
Phase: NA • Sponsor: Stanford University • Aim: Diagnosis
Last updated Jul 26, 2026 00:00 UTC
-
New scan could spot prostate cancer more accurately
Diagnosis Recruiting nowThis Phase 3 trial is testing whether combining a special PET scan (PSMA PET) with MRI can detect prostate cancer better than standard methods. About 204 men with suspected prostate cancer will receive the combined imaging, and results will be compared to biopsy findings. The goa…
Phase: PHASE3 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
Can a simple swab predict who needs less radiation?
Diagnosis Recruiting nowThis trial is testing a new electrochemical method to monitor HPV infection in patients with head and neck cancers, specifically oropharyngeal carcinoma. The goal is to see if tracking HPV DNA levels during treatment can help personalize therapy, potentially allowing some patient…
Phase: NA • Sponsor: Masaryk Memorial Cancer Institute • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
AR glasses may revolutionize vertigo diagnosis
Diagnosis Recruiting nowThis study tests whether wearable augmented reality (AR) glasses can diagnose vertigo as accurately as standard eye-movement exams. About 200 adults with vertigo will try both methods during one visit. If successful, AR glasses could make vertigo assessment faster and more access…
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer cells
Diagnosis Recruiting nowThis early-stage trial tests a fluorescent dye attached to the cancer drug nivolumab. The dye is meant to make cancer cells glow during surgery, helping surgeons remove them more precisely. The study will enroll 40 people with head and neck cancer who are already scheduled for su…
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
New imaging agent could spot multiple cancers with one scan
Diagnosis Recruiting nowThis study is testing a new type of PET scan that uses special radioactive tracers to find and map solid tumors in the body. The tracers target a protein called Trop2, which is often found on cancer cells. Researchers will enroll 400 people with various cancers (including bladder…
Phase: PHASE2, PHASE3 • Sponsor: RenJi Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Spit test could spot oral cancer before it spreads
Diagnosis Recruiting nowThis study is testing whether a simple saliva sample can help diagnose oral squamous cell carcinoma (OSCC), a type of mouth cancer. Researchers will look for specific DNA changes (methylation) in the saliva of 30 patients with OSCC and compare them to 30 healthy controls. If the …
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
New PET scan targets hidden cancers with precision
Diagnosis Recruiting nowThis study tests a special PET/CT scan that uses radioactive tracers to find cancers that have a protein called CD70 on their surface. The cancers being studied include kidney cancer, lymphoma, and nasopharyngeal cancer. About 300 adults will receive an injection of the tracer an…
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Mouth ultrasound could slash unnecessary throat punctures
Diagnosis Recruiting nowThis study compares two ways to diagnose a peritonsillar abscess (a pus pocket near the tonsils): the usual physical exam versus adding a small ultrasound probe inside the mouth. About 368 adults with suspected abscess will take part. The goal is to see if ultrasound improves acc…
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Ultrasound may replace scopes for Kids' vocal cord checks
Diagnosis Recruiting nowThis study looks at whether a simple ultrasound at the bedside can reliably detect vocal fold motion impairment in children who are on noninvasive breathing support in the ICU. About 50 children will get two ultrasounds of their vocal folds—one while on the breathing machine and …
Sponsor: Nemours Children's Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Throat cancer diagnosis could get faster and more accurate with new ultrasound technique
Diagnosis Recruiting nowThis study tests whether adding a special ultrasound of the tonsils to standard exams helps doctors diagnose oropharyngeal cancer more accurately. About 180 patients with suspected throat cancer will be randomly assigned to either standard diagnostics alone or standard diagnostic…
Phase: NA • Sponsor: Tobias Todsen • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Could an AI device replace the Doctor's visit for kids with ear infections and asthma?
Diagnosis Recruiting nowThis study tests a new device that uses artificial intelligence to help diagnose ear infections, strep throat, and asthma flare-ups in children. About 84 kids aged 3 to 17 will either use the device at home with a doctor's video visit or receive standard in-person care. The goal …
Phase: NA • Sponsor: Medentum Innovations • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
New ultrasound wand could spot mouth cancer without a knife
Diagnosis Recruiting nowThis study is testing a new, high-frequency ultrasound probe that goes inside the mouth to look at suspicious spots. The goal is to see if it can accurately measure how deep a mouth cancer goes, which might help doctors diagnose it without always needing a surgical biopsy. The st…
Phase: NA • Sponsor: University of Pisa • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
New light device aims to end guesswork in ear infection diagnosis
Diagnosis Recruiting nowThis study tests a new device that uses special lights to look at the eardrum and detect fluid behind it, which is a sign of middle ear infection. The goal is to make diagnosis more accurate than current methods. The study will include 150 people of all ages who are scheduled for…
Sponsor: University of California, Irvine • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
New PET scan aims to spot hidden scar tissue
Diagnosis Recruiting nowThis study tests a special PET/CT scan that uses a tracer called FAPI-74 to find fibrosis (scar-like tissue) in the body. It includes 45 adults with conditions like head and neck cancer or tuberculosis that can cause fibrosis. The goal is to see how well the scan shows fibrosis, …
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
Simple mouth swab could spot hidden throat cancer early
Diagnosis Recruiting nowThis study is testing whether a simple mouth rinse can detect HPV-related throat cancer early, before symptoms appear. Researchers will compare results from 200 people with throat cancer and 200 healthy volunteers matched by age, sex, and background. If accurate, this test could …
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
New 'Ultrasound for the Ear' could slash unnecessary antibiotics in kids
Diagnosis Recruiting nowThis study tests whether a new imaging technology called optical coherence tomography (OCT) can help doctors more accurately diagnose ear infections in children. Researchers will compare standard ear exams with OCT-enhanced exams in 235 children. The goal is to see if OCT reduces…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
Could a quicker CT scan replace MRI for oral cancer staging?
Diagnosis Recruiting nowThis study tests whether a special type of CT scan (dual-energy CT) can be as good as MRI for staging oral and throat cancers. Staging helps doctors decide the best treatment. If the CT works just as well, patients might avoid an extra MRI, get treated faster, and free up MRI mac…
Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
AI learns to see inside your throat: new tool could catch disease early
Diagnosis Recruiting nowThis study is developing an artificial intelligence system that can recognize different parts of the throat and nasal passages and detect abnormal growths or lesions. Researchers will train the AI using thousands of endoscopy images and then test its accuracy against doctors with…
Sponsor: Ruijin Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
AI takes on ear infections: could cut unnecessary antibiotics in kids
Diagnosis Recruiting nowThis study tests whether an AI-powered app can help doctors more accurately diagnose ear infections in young children (6-24 months) with cold symptoms. Researchers will compare standard ear exams with the AI app's analysis of eardrum photos. The goal is to see if the AI reduces u…
Phase: NA • Sponsor: Timothy Shope • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
New scan could sharpen cancer detection
Diagnosis Recruiting nowThis early-stage study is testing a new imaging agent called 68Ga-FL-031 to see if it can better detect and stage certain cancers, including small cell lung, breast, and nasopharyngeal tumors. Ten adults with suspected or confirmed cancer will receive both the new PET scan and a …
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
Your phone could soon diagnose asthma and COPD with sound waves
Diagnosis Recruiting nowThis study tests whether a smartphone app (AWARE) can accurately detect and monitor lung diseases like asthma, COPD, and cystic fibrosis by analyzing sound waves from the phone's speaker and microphone. Researchers will enroll 800 people aged 8-70, including healthy volunteers an…
Phase: NA • Sponsor: Indiana University • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
Could a light swab stop nose surgery infections?
Prevention Recruiting nowThis pilot study is testing whether a light-activated gel applied inside the nose before surgery can prevent infections afterward. Eighty adults having nasal surgery will either get the light treatment or a plain gel. Researchers will track who needs antibiotics for infection wit…
Phase: NA • Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Prevention
Last updated Jun 27, 2026 13:07 UTC
-
Could a probiotic cream shield cancer patients from radiation burns?
Prevention Recruiting nowThis early-stage trial tests a cream made from inactivated Akkermansia muciniphila bacteria to prevent skin injury in 40 breast or head/neck cancer patients receiving radiation. The cream is applied three times daily to the radiation area. The main goal is to see if it is safe an…
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Prevention
Last updated Jun 27, 2026 13:04 UTC
-
Can a common antiseptic spray stop radiation burns in cancer patients?
Prevention Recruiting nowThis study tests whether a chlorhexidine spray can prevent severe skin reactions caused by radiation therapy in people with nasopharyngeal cancer. About 148 participants will use the spray or a placebo during their treatment. The goal is to see if the spray reduces the chance of …
Phase: PHASE3 • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:26 UTC
-
Common pain gel could shield cancer patients from radiation burns
Prevention Recruiting nowThis study tests whether a gel containing diclofenac, a common anti-inflammatory drug, can prevent severe skin irritation caused by radiation therapy. About 156 adults with head/neck or breast cancer will apply the gel or a placebo to the treated skin three times daily during the…
Phase: NA • Sponsor: The Second Affiliated Hospital of Hainan Medical University • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Cockroach extract may shield cancer patients from radiation burns
Prevention Recruiting nowThis study tests a liquid made from cockroach extract (Meilian Fuxin) to prevent severe skin damage in head and neck cancer patients receiving radiation therapy. About 60 participants will apply the solution to their skin during treatment. The goal is to see if it reduces the ris…
Phase: PHASE2, PHASE3 • Sponsor: West China Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Hope for cancer patients: drug may shield ears from chemo damage
Prevention Recruiting nowThis study tests whether acetylcysteine, a drug often used for other purposes, can prevent hearing loss caused by cisplatin chemotherapy. About 40 adults receiving high-dose cisplatin will get either acetylcysteine or a placebo after each chemo session. Researchers will measure h…
Phase: PHASE2 • Sponsor: Siriraj Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
Eye drops may shield tear ducts from radioactive iodine damage
Prevention Recruiting nowThis phase 3 trial tests whether using artificial tears after radioactive iodine therapy can prevent tear duct blockage in thyroid cancer patients. Radioactive iodine can collect in tears and damage tear ducts, leading to blockage. 100 adults receiving high-dose radioactive iodin…
Phase: PHASE3 • Sponsor: Vanderbilt University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 07:55 UTC
-
New drug aims to ease painful mouth sores for head and neck cancer patients
Symptom relief Recruiting nowThis phase II trial tests whether adding BMX-001 to standard symptom management can reduce severe mouth sores in head and neck cancer patients receiving chemoradiation. About 98 participants will receive either BMX-001 or a placebo alongside usual care. The goal is to see if BMX-…
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Aug 18, 2026 02:00 UTC
-
New allergy spray trial aims to help teens breathe easier
Symptom relief Recruiting nowThis study tests if Dymista nasal spray safely eases allergy symptoms like sneezing, stuffy nose, and itchy eyes in Chinese teenagers aged 12 to 17. About 100 participants will use the spray twice daily for two weeks. The goal is to see if symptoms improve, not to cure allergies.
Phase: PHASE4 • Sponsor: Viatris Inc. • Aim: Symptom relief
Last updated Aug 18, 2026 02:00 UTC
-
New injection could tame seasonal allergy symptoms for those failed by standard treatments
Symptom relief Recruiting nowThis Phase 3 trial tests an investigational injection called SHR-1819 in adults aged 18 to 75 with seasonal allergic rhinitis (hay fever) who haven't gotten enough relief from standard treatments like nasal sprays or antihistamines. The study compares the drug to a placebo to see…
Phase: PHASE3 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Aug 18, 2026 02:00 UTC
-
Migraine drug rimegepant tested for safety in kids and teens
Symptom relief Recruiting nowThis study tests the long-term safety of rimegepant, a migraine medication taken as a dissolving tablet, in children and adolescents aged 6 to 18. About 600 participants with a history of migraine will take the drug as needed for up to one year. The main goal is to check for side…
Phase: PHASE3 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
New hope for kids with migraines: rimegepant enters final testing
Symptom relief Recruiting nowThis study tests whether rimegepant, a fast-dissolving tablet, can safely relieve migraine pain in children and adolescents aged 6 to 18. About 2,100 participants will receive either the drug or a placebo during a migraine attack. The main goal is to see if more kids become pain-…
Phase: PHASE3 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
New pill aims to shorten COPD Flare-Ups from common cold
Symptom relief Recruiting nowThis study tests an oral drug called vapendavir in 180 adults with COPD who catch a rhinovirus (common cold). The goal is to see if it can reduce the severity and length of breathing symptoms compared to a placebo. Participants are randomly assigned to one of two doses or a place…
Phase: PHASE2 • Sponsor: Altesa Biosciences, Inc. • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Electric zaps to the forehead may help restore lost sense of smell
Symptom relief Recruiting nowThis study tests whether combining a mild electrical nerve stimulation on the forehead with standard smell training can improve smell function in adults with smell loss. Participants use a small device at home for 8 weeks while smelling four different odors. Researchers measure c…
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Early jaw exercises may prevent lockjaw in cancer patients
Symptom relief Recruiting nowThis study tests whether closely watching jaw movement and starting physical therapy early can prevent or reduce trismus (jaw tightness) in people receiving radiation for head and neck cancer. Thirty adults will be checked weekly during treatment and given jaw exercises if their …
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
A gentle touch against coughs and colds: could manual therapy shorten respiratory illness?
Symptom relief Recruiting nowThis study tests whether adding lymphatic pump osteopathic manipulative therapy (OMT) to standard care helps older adults recover faster from respiratory illnesses like bronchitis, sinusitis, or pneumonia. Participants aged 65 to 100 with a new respiratory diagnosis will receive …
Phase: NA • Sponsor: Geisinger Clinic • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New VR software aims to stop cybersickness before it starts
Symptom relief Recruiting nowThis study tests a new software called Motion Reset that may prevent or reduce cybersickness—symptoms like nausea, dizziness, and headache—when using virtual reality. Healthy adults aged 18 to 60 will try different VR experiences and then play a commercial VR game while reporting…
Phase: NA • Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New devices aim to soothe sore throats without drugs
Symptom relief Recruiting nowThis study will test four medical devices (HMG, PHN, PHR, TUR) in 160 adults with sore throat from acute pharyngitis or viral tonsillitis. The goal is to see if they are safe and help reduce symptoms like pain when swallowing. Participants will use the device for up to 7 days and…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Ancient herbal blend put to the test against hay fever
Symptom relief Recruiting nowThis trial investigates whether Yupingfeng Powder, a traditional Chinese herbal formula, can improve symptoms and quality of life in adults with allergic rhinitis (hay fever). Participants will take the herbal granules or a placebo twice daily for 8 weeks, with follow-up for anot…
Phase: PHASE2, PHASE3 • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Can a bandage inside the throat ease tonsil surgery pain?
Symptom relief Recruiting nowThis trial tests whether placing a special synthetic membrane called Suprathel 250 on the wound after tonsil removal can reduce pain and improve healing. About 80 adults scheduled for tonsillectomy will either receive the membrane or have the wound left to heal on its own. Resear…
Phase: NA • Sponsor: Alaa Emara • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Wearable sensors may personalize balance rehab for older adults — a trial puts them to the test
Symptom relief Recruiting nowThis trial tests a wearable-sensor system called MINDGAPS that tracks eye and body movements during balance exercises. Researchers want to see if it can improve dizziness and stability in older adults with vestibular hypofunction — a common cause of falls. The study also checks w…
Phase: NA • Sponsor: University of Montana • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Can an RNA shot teach the immune system to ignore cedar pollen?
Symptom relief Recruiting nowThis early-stage trial tests an experimental RNA immunotherapy called ITI-9001 in adults with Japanese cedar pollen allergy. The treatment aims to retrain the immune system to reduce allergic reactions. Researchers are primarily checking safety and how well people tolerate the sh…
Phase: PHASE1 • Sponsor: Immunomic Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Custom cochlear implant tuning based on ear anatomy may sharpen hearing in noise and music for the single-sided deaf
Symptom relief Recruiting nowThis trial tests whether programming a cochlear implant based on the individual's inner ear anatomy (anatomy-based fitting) improves speech understanding in noisy environments and music perception compared to standard programming. The study enrolls adults with single-sided deafne…
Phase: NA • Sponsor: University Hospital, Antwerp • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
New lozenge aims to ease radiation mouth sores for hours
Symptom relief Recruiting nowThis phase 3 trial tests whether a lozenge called BupiZenge, which contains the long-acting painkiller bupivacaine, can relieve mouth pain from radiation therapy better than the standard lidocaine rinse. About 150 adults with head and neck cancer will be randomly assigned to one …
Phase: PHASE3 • Sponsor: OncoZenge AB • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Cochlear implants tailored to ear anatomy could sharpen hearing
Symptom relief Recruiting nowThis study tests whether programming a cochlear implant based on a person's inner ear anatomy improves hearing compared to the standard approach. Participants are adults with severe hearing loss who use a cochlear implant in one ear and a hearing aid in the other. Researchers wil…
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Can tweaking cochlear implant settings help people hear better in noise?
Symptom relief Recruiting nowThis study is testing whether changing the low-frequency settings on a cochlear implant can improve hearing for people who are deaf in one ear but have normal hearing in the other. Twenty-two adults will try four different sound maps during their first month after implant activat…
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Can a simple additive make eye surgery safer for the heart?
Symptom relief Recruiting nowThis trial tests whether adding dexmedetomidine or magnesium sulphate to lidocaine for a peribulbar block (anesthesia around the eye) helps keep heart rate and blood pressure steady during dacryocystorhinostomy (tear duct surgery) under general anesthesia. Sixty adults undergoing…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New combo therapy aims to quiet dizziness and worry after concussion
Symptom relief Recruiting nowThis study tests a new treatment called ACTIVE that combines counseling (Acceptance and Commitment Therapy) with balance exercises for people with mild traumatic brain injury. Researchers want to see if it helps reduce dizziness and anxiety better than standard balance therapy al…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can steroids reverse nerve damage from cancer radiation?
Symptom relief Recruiting nowThis study tests high-dose steroids (methylprednisolone or prednisone) in 35 head and neck cancer survivors who have nerve damage from past radiation. The goal is to find the best dose that improves symptoms like tongue weakness while limiting side effects. Participants must be a…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Mouth spray could tame agonizing swallowing pain during cancer radiation
Symptom relief Recruiting nowThis clinical trial tests whether a doxepin solution spray can relieve severe breakthrough pain when swallowing, a common side effect of radiation therapy for nasopharyngeal carcinoma. About 178 patients will be randomly assigned to receive either the doxepin spray or a placebo s…
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Could a common antidepressant and seizure drug tame Meniere's vertigo?
Symptom relief Recruiting nowThis study tests whether a combination of two existing drugs, nortriptyline and topiramate, can reduce vertigo and other symptoms in people with Meniere's disease. Forty adults with active Meniere's will take the drugs or a placebo for 8 weeks. The goal is to see if this approach…
Phase: PHASE4 • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New Triple-Action pill takes on cold and flu symptoms
Symptom relief Recruiting nowThis study tests a new pill containing three ingredients (dipyrone, caffeine, and chlorpheniramine) to see if it works as well as a standard cold medicine for relieving stuffy nose and other cold and flu symptoms. About 620 adults with early cold or flu symptoms will take either …
Phase: PHASE3 • Sponsor: Brainfarma Industria Química e Farmacêutica S/A • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New devices aim to ease cold symptoms – but will they work?
Symptom relief Recruiting nowThis study is testing four medical devices (PIR, NS, NHE, NHG) in 150 adults with acute viral rhinitis, rhinosinusitis, or rhinopharyngitis (common cold). The goal is to see if they are safe and help reduce symptoms like sneezing, runny nose, and sore throat. Participants use the…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can sexology consultations restore intimacy after throat cancer surgery?
Symptom relief Recruiting nowThis study tests whether a series of sexology consultations can help people who had their voice box removed due to throat cancer, along with their partners, feel better about their intimate lives. The program involves individual talks with a trained sexology nurse and questionnai…
Sponsor: Institut Claudius Regaud • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a constipation drug help head and neck cancer patients before surgery?
Symptom relief Recruiting nowThis study tests whether a drug called methylnaltrexone is safe for people with head and neck cancer when taken for two weeks before their surgery. The drug is already used for constipation, but researchers want to see if it can be given safely in this setting. About 25 adults wi…
Phase: PHASE4 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Which expander hurts less? new study for kids with crossbite
Symptom relief Recruiting nowThis study compares two dental devices—the Leaf expander and the Hyrax expander—in 30 children aged 6 to 12 who have a crossbite (when upper teeth sit inside lower teeth). The main goal is to see which expander causes less pain during the first week. Researchers will also measure…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Can early speech therapy help cancer patients swallow and speak better after surgery?
Symptom relief Recruiting nowThis study looks at whether starting speech and swallowing therapy early — before and just after surgery — can help people with head and neck cancer recover better. Forty patients will either get early therapy sessions with a speech-language pathologist or the usual care. The mai…
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
3D-Printed nose models could boost sinus rinse results
Symptom relief Recruiting nowThis study tests whether a 3D-printed replica of a person's own nose can help them position their head better when using steroid nasal rinses. 200 adults with chronic sinusitis will use a daily steroid rinse for 8 weeks, with some getting the 3D model to guide their head position…
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Fish oil might keep you warmer in the cold, study suggests
Symptom relief Recruiting nowThis study tests whether taking fish oil for 12 weeks can help the body adapt to cold by activating brown fat, which burns energy to produce heat. Thirty healthy adults aged 18-40 will take either fish oil or a placebo and then undergo a cold chamber challenge. Researchers will m…
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Robotic surgery plus daily swallowing therapy aims to keep head and neck cancer patients eating and speaking normally
Symptom relief Recruiting nowThis study tests whether a personalized 12-week speech, swallowing, and voice rehabilitation program can help preserve swallowing function in head and neck cancer patients after minimally invasive robotic surgery. About 53 participants will be enrolled, including those having sur…
Phase: NA • Sponsor: Christian Simon • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Simple head turn may stop vertigo in its tracks
Symptom relief Recruiting nowThis study tests whether a simple head-and-body movement called the Epley maneuver can quickly relieve dizziness from benign paroxysmal positional vertigo (BPPV) in the emergency department. About 118 adults with BPPV will either get the real maneuver or a fake one. Researchers w…
Phase: NA • Sponsor: American University of Beirut Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Can video games help you find your voice? VR therapy trial launches
Symptom relief Recruiting nowThis study tests whether virtual reality (VR) games can make speech therapy more fun and improve how often people practice. Researchers will enroll 30 adults with voice disorders at the Glenrose Rehabilitation Hospital. Participants will use VR speech therapy games at home and in…
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Herbal drink may soothe radiation mouth pain in cancer patients
Symptom relief Recruiting nowThis phase 3 trial tests whether Houyanqing Oral Liquid, a Chinese herbal mix, can prevent or reduce severe mouth sores caused by radiation therapy in 386 nasopharyngeal cancer patients. Participants take the liquid four times daily during radiation, alongside standard care. The …
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Sinus surgery may ease sleep problems in nasal polyp patients
Symptom relief Recruiting nowThis study looks at whether endoscopic sinus surgery can improve sleep in people with chronic sinusitis and nasal polyps. Researchers will measure sleep quality before and after surgery in 30 participants. The goal is to see if removing polyps and opening blocked sinuses helps wi…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Zapping nasal nerves could stop runny noses
Symptom relief Recruiting nowThis study tests a device called NOVOCLEAR™ that uses pulsed energy to treat chronic rhinitis, a condition causing long-term runny nose, congestion, itching, and sneezing. The treatment targets nerves in the nose to reduce symptoms. Researchers will enroll 30 adults who haven't g…
Phase: NA • Sponsor: Aventix Medical Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New throat sprays aim to soothe your cold cough
Symptom relief Recruiting nowThis study tests two throat sprays (CDN and CW) for adults with a cough from a viral cold. About 58 people will use one of the sprays for 7 days and report how well it works and any side effects. The goal is to see if these sprays are safe and help ease cough symptoms.
Phase: PHASE4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Throat plumping injection could give cancer survivors their voice back
Symptom relief Recruiting nowSome head and neck cancer survivors develop velopharyngeal dysfunction (VPD), where the soft palate doesn't close properly, causing nasal-sounding speech and trouble swallowing. This study tests a simple injection that plumps up the back of the throat to improve closure. Research…
Phase: NA • Sponsor: Vanessa Torrecillas • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Daily exercise may ease radiation side effects for head and neck cancer patients
Symptom relief Recruiting nowThis study tests whether a daily physical activity routine, started before and continued during radiotherapy, can improve physical function and quality of life for head and neck cancer patients. 80 patients with tumors of the oropharynx, larynx, or hypopharynx will be randomly as…
Phase: NA • Sponsor: Sahlgrenska University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Black seed oil takes on steroids in ear eczema showdown
Symptom relief Recruiting nowThis study compares black seed (Nigella sativa) oil to standard steroid ear drops for treating eczema in the ear canal. 85 adults with ear eczema will use either the oil or steroid drops twice daily for 10 days. Researchers will measure changes in inflammation, itching, and pain …
Phase: NA • Sponsor: Bezmialem Vakif University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could a cystic fibrosis drug ease stubborn sinus infections?
Symptom relief Recruiting nowThis early study tests whether ivacaftor, a drug used for cystic fibrosis, can help people with chronic sinusitis caused by hard-to-treat bacteria. Twenty adults will receive either ivacaftor plus standard care or standard care alone for 14 days. Researchers will check safety, sy…
Phase: EARLY_PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Sniffing out solutions: new device aims to restore lost smell in seniors
Symptom relief Recruiting nowThis study tests whether a device called ScentCare, used with a companion app, can improve smell and well-being in adults aged 60 and older who have lost their sense of smell. Participants will use the device or solve Sudoku puzzles twice daily for three months. Researchers will …
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Can a sleep apnea machine help people with collapsing airways walk farther?
Symptom relief Recruiting nowThis study tests whether using a CPAP machine during a 6-minute walk test helps people with excessive central airway collapse (ECAC) walk farther and feel less breathless. ECAC is a condition where the central airways narrow or collapse during breathing, making exercise difficult…
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Smart radiotherapy aims to cut cancer treatment side effects
Symptom relief Recruiting nowThis study tests a new way to give radiation for head and neck cancer. Instead of a fixed plan, the radiation is adjusted daily to match changes in the patient's body. The goal is to lower side effects like trouble swallowing and dry mouth. About 40 adults with throat or voice-bo…
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
At-home treatments may bring back smell for long COVID sufferers
Symptom relief Recruiting nowThis study tests two at-home treatments—smell training and a gentle nerve stimulation device—for people with long COVID who have lost or distorted their sense of smell. About 145 adults will do daily sessions at home and attend three clinic visits over 12 weeks. The goal is to se…
Phase: PHASE2, PHASE3 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
EATING YOUR WAY TO CLEARER SKIN? NEW STUDY TESTS DIET FOR ECZEMA
Symptom relief Recruiting nowThis study tests whether a diet low in saturated fats and rich in whole grains, fruits, and vegetables can reduce the severity of atopic dermatitis (eczema) in young adults. Researchers will track changes in skin symptoms and barrier function over two months. The goal is to see i…
Phase: NA • Sponsor: National University of Singapore • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New shot could tame seasonal sniffles for good?
Symptom relief Recruiting nowThis study tests an injection called TQH2722 in 300 adults with seasonal allergic rhinitis (hay fever). The goal is to see if it safely eases symptoms like sneezing, stuffy nose, and itchy eyes when added to standard allergy treatments. Participants will receive the injection and…
Phase: PHASE2 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Vibrating belt could help people with balance disorders walk steadier
Symptom relief Recruiting nowThis study tests whether a special belt that vibrates can help people with balance disorders walk better and feel more steady. Researchers will enroll 90 adults aged 18-80 who have balance issues from conditions like inner ear problems or ataxia. Participants will use the belt an…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New app aims to boost allergy treatment adherence
Symptom relief Recruiting nowThis study tests whether a mobile app can help people with allergic rhinitis (hay fever) stay on their allergy immunotherapy (allergy shots or under-the-tongue drops) for the full 3 years. Many people stop early, reducing the treatment's effectiveness. The app provides reminders …
Phase: NA • Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Real-World allergy treatment under the microscope
Symptom relief Recruiting nowThis study tracks how adults with grass pollen allergy use Grassmuno® in everyday medical practice. Researchers will monitor treatment adherence and injection schedules over two years. The goal is to understand how well patients stick with the therapy and how it controls their sy…
Sponsor: Allergy Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 11:04 UTC
-
Music before surgery: a simple tune to calm nerves?
Symptom relief Recruiting nowThis study tests whether a 20-minute session of passive music therapy, delivered through an app just before entering the operating room, can lower anxiety and pain in adults undergoing ear, nose, or throat surgery. Five hundred participants will be randomly assigned to receive mu…
Phase: NA • Sponsor: Clinique Saint-Vincent • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Cat allergy treatment gets a needle upgrade: fewer shots, same hope
Symptom relief Recruiting nowThis study tests a new method for treating cat allergies called intralymphatic immunotherapy (ILIT), where allergen extracts are injected directly into a lymph node. Thirty-six adults with cat-triggered allergic rhinitis and asthma will receive 3-4 ultrasound-guided injections. T…
Phase: PHASE1, PHASE2 • Sponsor: University of Zurich • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New nasal spray delivery could finally pop ear troubles away
Symptom relief Recruiting nowThis study tests whether a new nasal spray system that delivers fluticasone deeper into the nose can relieve Eustachian tube dysfunction (ETD) — a condition causing ear pressure, popping, and muffled hearing. About 80 adults with chronic ETD will receive either the active spray o…
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
GPS for your sinuses? new trial tests Navigation-Guided balloon surgery
Symptom relief Recruiting nowThis study tests whether using a navigation system during balloon sinus dilation improves success rates for people with chronic maxillary sinusitis. Fifty adults who have not had prior sinus surgery will be randomly assigned to receive either standard balloon dilation or navigati…
Phase: PHASE2, PHASE3 • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New inhaler may ease mouth pain for head and neck cancer patients
Symptom relief Recruiting nowThis study tests if a drug called Sapylin, given through an inhaler, can prevent or reduce painful mouth sores caused by chemotherapy and radiation for nasopharyngeal cancer. About 180 adults with advanced cancer will be randomly assigned to receive either Sapylin or the standard…
Phase: PHASE3 • Sponsor: Affiliated Hospital of Guangdong Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Virtual reality could help fix your balance
Symptom relief Recruiting nowThis study tests whether virtual reality exercises can help people with balance problems caused by a weak inner ear on one side. 48 adults will be split into three groups: one doing standard balance exercises, one using VR, and one doing both. The goal is to see if VR can reduce …
Phase: NA • Sponsor: Istanbul Medipol University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Can nasal sprays replace antibiotics for sinus infections? major study aims to find out
Symptom relief Recruiting nowThis study looks at whether antibiotics, nasal steroids, or nasal irrigation work best for treating sinus infections. About 3,720 adults with acute sinusitis will be randomly assigned to one of these treatments or a placebo. The goal is to see which approach provides the most sym…
Phase: PHASE4 • Sponsor: Daniel Merenstein • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
VR therapy offers new hope for 'Sea Legs' disorder
Symptom relief Recruiting nowThis study tests a virtual reality therapy for Mal de Débarquement Syndrome (MdDS), a balance disorder causing persistent rocking or swaying sensations. Two hundred participants will undergo five days of treatment using VR to retrain their balance system. The goal is to improve s…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New MRI technique aims to spare saliva glands during cancer radiation
Symptom relief Recruiting nowThis Phase 2 trial tests whether using MRI to map saliva ducts before radiation therapy can reduce dry mouth in people with oropharyngeal cancer. About 98 participants will be randomly assigned to standard radiation planning or a new approach that spares the parotid ducts. The ma…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Smart radiation aims to cut severe mouth sores in head and neck cancer
Symptom relief Recruiting nowThis study compares standard radiation therapy to a newer method called dose painting for people with head and neck cancer. The goal is to see if dose painting causes fewer severe mouth ulcers one year after treatment. About 100 participants will be randomly assigned to receive e…
Phase: NA • Sponsor: Oslo University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New allergy shot alternative could ease sneezing and itchy eyes
Symptom relief Recruiting nowThis study tests a new under-the-tongue treatment (MM09) for people with rhinitis or rhinoconjunctivitis caused by house mite allergy, with or without mild asthma. About 736 participants aged 12 to 65 will receive either MM09 or a placebo to see if it reduces allergy symptoms and…
Phase: PHASE3 • Sponsor: Inmunotek S.L. • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Herbal nasal rinse may ease sinus surgery recovery
Symptom relief Recruiting nowThis study looks at whether a Chinese herbal medicine nasal rinse can help people feel better and heal faster after sinus surgery for chronic sinusitis. About 80 adults who have already had surgery will use the rinse for two months. The goal is to see if it reduces symptoms and i…
Phase: PHASE2 • Sponsor: Taichung Veterans General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Head exercises may cut falls in Alzheimer's patients
Symptom relief Recruiting nowThis study tests whether vestibular therapy—a set of head-movement exercises done with a physical therapist—can reduce falls in people with Alzheimer's disease who also have inner-ear balance problems. About 100 participants aged 60 and older will receive either the therapy or st…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
New nerve block may beat morphine for scoliosis surgery pain
Symptom relief Recruiting nowThis study compares two ways to manage pain after scoliosis surgery: a nerve block called MTP (injected near the spine) versus patient-controlled morphine (PCA). Forty adults with idiopathic scoliosis will be randomly assigned to one of the two methods. The main goal is to see wh…
Phase: NA • Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
In-Clinic polyp removal could replace costly sinus surgery
Symptom relief Recruiting nowThis study compares two ways to treat chronic sinusitis with nasal polyps: a new in-clinic procedure done under local anesthesia versus standard sinus surgery in an operating room. Researchers will enroll 140 adults to see if the in-clinic approach controls symptoms just as well,…
Phase: NA • Sponsor: Ottawa Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New nasal numbing sprays tested in teens for Pain-Free nose surgeries
Symptom relief Recruiting nowThis study tests two nasal sprays, GOPRELTO and NUMBRINO, that numb the nose for procedures like surgery or exams. It involves 40 teens aged 12 to 17. Researchers will measure how the drug moves through the body and check for side effects.
Phase: PHASE3 • Sponsor: Noden Pharma • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Lavender scent tested as natural calm for nose and throat procedures
Symptom relief Recruiting nowThis study tests whether smelling lavender essential oil during awake ear, nose, and throat procedures can lower anxiety and pain. About 184 adults will be randomly assigned to receive either lavender aromatherapy or a placebo (odorless liquid). Participants will rate their anxie…
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Neck mobilization may ease Meniere's dizziness
Symptom relief Recruiting nowThis study tests whether adding neck therapy (cervical mobilization) to standard balance exercises can reduce dizziness and improve balance in people with Meniere's disease. 33 adults with Meniere's will be split into three groups: one getting only their usual medication, one add…
Phase: NA • Sponsor: Abant Izzet Baysal University • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New hearing aid tech aims to cut through noise
Symptom relief Recruiting nowThis study tests a new noise-reduction feature for hearing aids that uses deep neural networks to help people hear speech better in noisy settings. Fifty adults with mild-to-moderate hearing loss will listen to sentences at different noise levels while using three settings: no no…
Phase: NA • Sponsor: Purdue University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Stick it out: simple tongue trick could ease radiation side effects
Symptom relief Recruiting nowThis study tests a simple technique called tongue-out radiation therapy (TORT) for people with head and neck cancer. By sticking out the tongue during treatment, the radiation dose to the mouth and throat may be lowered, potentially reducing painful side effects like trouble swal…
Phase: NA • Sponsor: Yvonne Mowery • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New combo therapy aims to stop the spins for BPPV sufferers
Symptom relief Recruiting nowThis study looks at whether adding Brandt-Daroff exercises to the usual GANS maneuver can reduce dizziness and improve quality of life for people with BPPV, a common inner-ear condition that causes brief spinning spells. About 30 adults with BPPV will be split into two groups: on…
Phase: NA • Sponsor: Foundation University Islamabad • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Could one dose of methadone spare kids from extra pain meds after tonsil surgery?
Symptom relief Recruiting nowThis study compares a single dose of methadone (a long-acting opioid) given during surgery to standard short-acting opioids for pain relief after tonsillectomy in children ages 3 to 17. The goal is to see if methadone reduces the need for extra pain medication in the recovery roo…
Phase: PHASE4 • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Ocean in a bottle? new study tests seawater sprays for sinus relief
Symptom relief Recruiting nowThis study looks at how well seawater nasal sprays work in everyday life for people with nasal and sinus issues like colds, allergies, or after surgery. About 1065 people of all ages, including pregnant women, will use the sprays and report their symptoms. The goal is to see if t…
Phase: NA • Sponsor: Laboratoire de la Mer • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New nasal spray aims to ease chronic sinus troubles
Symptom relief Recruiting nowThis early-stage study tests a new nasal spray called VVN432 in 60 people. First, healthy volunteers will check for safety. Then, patients with chronic sinusitis will test if it helps symptoms. The goal is to see if the spray is safe and how the body processes it.
Phase: PHASE1 • Sponsor: VivaVision Biotech, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Hearing aids tested to ease chemotherapy side effect
Symptom relief Recruiting nowThis study tests whether hearing aids can improve quality of life in cancer patients who develop hearing loss from platinum-based chemotherapy. Fifty-two adults currently on such chemotherapy and with confirmed hearing loss will be randomly assigned to receive a hearing aid or st…
Phase: NA • Sponsor: Institut de Cancérologie de Lorraine • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Can a simple seawater spray beat a stuffy nose?
Symptom relief Recruiting nowThis study is testing a seawater spray mixed with essential oils to see how well it relieves nasal congestion from colds, sinus infections, or allergies. About 114 people aged 12 and older will use the spray for 7 days. The main goal is to see if nasal blockage improves after 3 d…
Sponsor: Laboratoires Gilbert • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Breathing technique may ease ear issues in teens exposed to smoke
Symptom relief Recruiting nowThis study tests whether adding Buteyko breathing exercises to a smoking hygiene program can improve Eustachian tube function and lung health in 40 teens who are regularly exposed to secondhand smoke at home. Participants will practice the breathing technique daily for 6 months. …
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New device trains your head to beat motion sickness
Symptom relief Recruiting nowThis study tests a device called SWAN that guides people through head movements to reduce motion sickness and improve balance. It is for adults with inner ear disorders, motion sickness, or those recovering from vestibular schwannoma surgery. Participants use the device at home f…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New nasal spray aims to soothe seasonal allergy misery
Symptom relief Recruiting nowThis study tests a new nasal spray called ALDP001 for people with seasonal allergic rhinitis (hay fever). Researchers want to find the best dose and how often to use it to reduce symptoms like sneezing, stuffy nose, and runny nose. About 164 adults will take part, and their sympt…
Phase: PHASE2 • Sponsor: Alixer Nexgen Therapeutics Limited • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Can a simple seawater spray beat nasal congestion?
Symptom relief Recruiting nowThis study is testing a new seawater spray with essential oils to see if it safely relieves nasal congestion from colds, sinus infections, or allergies. About 101 people aged 12 and older will use the spray for 8 days. The main goal is to check if nasal stuffiness improves by at …
Phase: NA • Sponsor: Laboratoires Gilbert • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
New pill aims to ease stuffy noses and facial pain
Symptom relief Recruiting nowThis study tests a new tablet called HTMC0658 in 30 adults with chronic sinusitis (no nasal polyps). The goal is to see if it safely reduces symptoms like congestion, facial pain, and discharge over 12 weeks. Participants will have CT scans and symptom checkups to measure improve…
Phase: PHASE2 • Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. • Aim: Symptom relief
Last updated Jun 26, 2026 19:21 UTC
-
Scientists launch massive tissue collection to unlock secrets of head and neck diseases
Knowledge-focused Recruiting nowThis study aims to create a large collection of tissue samples from people with head and neck disorders, such as hearing loss, mouth diseases, and throat cancers. Researchers will use leftover surgical tissue and additional samples like blood, saliva, and cheek swabs to study the…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
Massive study aims to unlock mysteries of rare blood vessel disease
Knowledge-focused Recruiting nowThis study follows up to 4,000 people with vasculitis (a group of diseases that cause blood vessel inflammation) and healthy volunteers over many years. Researchers collect blood, urine, imaging, and genetic samples to learn how the disease develops and changes. The goal is to fi…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
Scientists use wearable sensors to decode mysterious exercise breathing disorder
Knowledge-focused Recruiting nowThis study looks at why some active young adults have trouble breathing during exercise due to their vocal cords closing when they shouldn't. Researchers will use a small wearable device on the neck, treadmill tests, and MRI scans to measure breathing patterns and vocal cord move…
Phase: PHASE2 • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Could a symptom registry unmask hidden migraine variants?
Knowledge-focused Recruiting nowThis study is building a large online registry of US adults who experience sinus, ear, dizziness, and headache symptoms, with or without a migraine diagnosis. Participants answer questions about their symptoms, how these affect daily life, and which treatments they have tried. Th…
Sponsor: Association of Migraine Disorders • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Researchers check safety of stent grafts used in aortic aneurysm surgery
Knowledge-focused Recruiting nowThis study looks back at medical records of 105 people who had a minimally invasive surgery called BEVAR to treat complex aortic aneurysms. Researchers want to see if two types of stent grafts (TUVA BX and iCover) are safe and work well. No new treatments are given; the study jus…
Sponsor: JOTEC GmbH • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
HPV throat cancer study tracks hidden infections in women and partners
Knowledge-focused Recruiting nowThis study is checking how often women who have HPV-positive throat cancer, or whose partner has it, also have HPV infections in their genital or anal areas. Researchers will compare these rates to similar women without cancer. The goal is to learn more about how HPV spreads and …
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
France launches massive virus surveillance in GP clinics
Knowledge-focused Recruiting nowThis study will track which respiratory viruses—like flu, COVID-19, and RSV—are circulating in French primary care clinics each winter. Up to 25,000 patients with cold or flu symptoms will provide a saliva or nose swab sample. The goal is to monitor virus activity and help guide …
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Can immune markers predict success of docetaxel chemoradiotherapy?
Knowledge-focused Recruiting nowThis study looks at immune markers in tumor tissue, saliva, stool, and blood from 250 head and neck cancer patients who cannot receive cisplatin chemotherapy. Researchers want to see if these markers can predict how well patients respond to chemoradiotherapy with docetaxel. The g…
Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Can a Dual-Task test predict falls in the elderly?
Knowledge-focused Recruiting nowThis study investigates how balance and cognitive tasks—like walking while doing mental math—affect each other in older adults. Researchers will compare healthy seniors with those who have experienced dizziness or falls, using wearable sensors and cognitive tests. The goal is to …
Sponsor: National Yang Ming Chiao Tung University • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Greek sinusitis study aims to personalize treatment by analyzing inflammation
Knowledge-focused Recruiting nowThis study will collect and analyze nasal tissue from 230 Greek patients with chronic sinusitis (with or without nasal polyps) to identify different inflammation patterns, called endotypes. By understanding these patterns, researchers hope to better match patients with the most e…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Massive device registry aims to improve patient safety
Knowledge-focused Recruiting nowThis study is a registry that collects information on the safety and effectiveness of Medtronic medical devices already on the market. It will include up to 100,000 people who have or will receive a Medtronic product for conditions like heart, nerve, or digestive disorders. The g…
Sponsor: Medtronic • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Brain scans reveal clues to why some people suffer worse balance problems
Knowledge-focused Recruiting nowThis study investigates why some people with bilateral vestibular hypofunction—a chronic balance disorder—experience more severe symptoms than others. Researchers will use advanced brain imaging (MRI) and a battery of vestibular function tests in about 80 patients and 40 healthy …
Sponsor: Shanghai 6th People's Hospital • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Can a simple test predict when smell returns?
Knowledge-focused Recruiting nowThis study follows 30 people with chronic sinusitis and nasal polyps who are starting dupilumab, a medication that can help restore smell. Researchers want to see if the degree of nasal blockage or specific electrical signals from the brain can predict who will regain their sense…
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Remote hearing tests could save cancer Patients' hearing
Knowledge-focused Recruiting nowThis study tests whether offering hearing tests close to home or remotely increases how many head and neck cancer patients get their hearing checked during treatment. Many patients on cisplatin chemotherapy or radiation near the ear can lose hearing, but not all complete recommen…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
FITBIT FOR CANCER: STUDY TESTS IF STEP COUNTS PREDICT SURVIVAL
Knowledge-focused Recruiting nowThis study is testing whether wearing a fitness tracker (like a Fitbit) can give doctors a better picture of how active cancer patients are, and whether that activity level relates to how well they are doing overall. About 590 people with various cancers will wear activity monito…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
New registry to monitor balloon procedure for Children's ear troubles
Knowledge-focused Recruiting nowThis study is a registry that will follow 300 children under 18 who receive a balloon dilation treatment for Eustachian tube dysfunction. Researchers will track how often the procedure fails and needs repeat surgery. The goal is to confirm the device's real-world performance in k…
Sponsor: Integra LifeSciences Corporation • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Cochlear implant study tracks Long-Term performance in hearing loss patients
Knowledge-focused Recruiting nowThis study follows 19 adults with hearing loss who already received a cochlear implant that releases a steroid to reduce inflammation. Researchers will check how well the implant works over 5 years by measuring electrical signals and tracking any side effects. The goal is to see …
Sponsor: Cochlear • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Taiwan launches genetic mapping study for throat cancer
Knowledge-focused Recruiting nowThis study aims to collect and analyze genetic information from 300 Taiwanese patients with oropharyngeal cancer. Researchers will use advanced DNA sequencing to find genetic changes linked to the disease. The goal is to improve understanding and help design future treatments or …
Sponsor: National Health Research Institutes, Taiwan • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Can smell training rewire the brain and immune system?
Knowledge-focused Recruiting nowThis study looks at people with smell loss caused by chronic rhinosinusitis. Participants will undergo a 3-month smell training program. Researchers will measure changes in smell function, mental health, and immune markers in blood and tissue samples. The goal is to understand th…
Phase: NA • Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Can a tongue trainer help cancer survivors speak and swallow better?
Knowledge-focused Recruiting nowThis study looks at tongue strength and endurance in people who have had part of their tongue removed due to oral tongue cancer. Researchers will use a device called the Iowa Oral Performance Instrument (IOPI) to measure tongue pressure. Some participants will also use the IOPI a…
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Can a fun fitness app help those who Can't smell? UK trial aims to find out
Knowledge-focused Recruiting nowThis 18-month study tests whether a smartphone app with game-like features can help adults aged 40+ with a reduced sense of smell become more active. 110 participants will be randomly assigned to either a full-dose programme aiming to double their daily steps or a low-dose contro…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Massive cancer database aims to unlock secrets of the disease
Knowledge-focused Recruiting nowThis study is building a huge registry of information and biological samples from adults with or at risk for many types of cancer, as well as healthy volunteers. Researchers will use this resource to study what causes cancer and how to better prevent, detect, and treat it. The re…
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Scientists dive deep into mysterious hearing fluctuations
Knowledge-focused Recruiting nowThis study aims to better understand disorders that cause hearing to fluctuate, such as Meniere's disease. Researchers will use advanced MRI scans and blood tests to look for biomarkers linked to hearing changes. The goal is to identify different types of these disorders and pave…
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD) • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Can exercise ease statin muscle pain? new study investigates
Knowledge-focused Recruiting nowThis pilot study looks at how different types and intensities of exercise affect muscle recovery in people taking statins compared to those not on statins. Researchers will test cycling and resistance training at various levels, measuring muscle damage markers and pain sensitivit…
Phase: NA • Sponsor: Raffaele Mazzolari • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Rare sinus cancer study aims to clarify treatment outcomes
Knowledge-focused Recruiting nowThis study follows people with a rare and advanced cancer of the nasal cavity and sinuses called T4 sinonasal adenoid cystic carcinoma. All participants receive the standard treatment: surgery followed by radiation therapy. The goal is to measure how long people live without the …
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
HIV and oral cancer: what blocks access to care?
Knowledge-focused Recruiting nowThis study talks to people living with HIV from diverse backgrounds to learn what helps or hinders them from getting oral health care and cancer prevention. Researchers will hold focus groups and use questionnaires to understand barriers and gather ideas for improvement. The goal…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could vitamin d deficiency trigger dizzy spells? new study investigates
Knowledge-focused Recruiting nowThis study is looking at whether people with a common inner-ear condition called benign paroxysmal positional vertigo (BPPV) have lower vitamin D levels than those without it. Researchers will compare vitamin D in 160 adults — half with BPPV and half without. The goal is to see i…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
MRI scans reveal hidden causes of speech issues in cleft palate kids
Knowledge-focused Recruiting nowThis study investigates why some children still have speech problems (velopharyngeal insufficiency) after cleft palate surgery. Researchers will use real-time MRI to look at how the soft palate moves and its muscle structure in children aged 7 to 12. By comparing children with di…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists harvest nose cells to test future medicines
Knowledge-focused Recruiting nowThis study collects nasal cells from 100 adults during planned nose surgery. The cells are grown in the lab to create a realistic model for testing how well drugs are delivered and work. The goal is to build a cell collection that helps improve treatments for respiratory infectio…
Phase: NA • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Smart probe could help surgeons remove all cancer in one go
Knowledge-focused Recruiting nowThis study tests a device called SpiderMass that analyzes tissue molecules in real time during tongue cancer surgery. The goal is to help surgeons instantly tell cancerous from healthy tissue, so they can remove all the tumor in one operation. Currently, about 15-30% of patients …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists sniff out Alzheimer's clues in nasal tissue
Knowledge-focused Recruiting nowThis study collects a small sample of tissue from inside the nose to learn how the sense of smell changes in people with Alzheimer's. Researchers will compare samples from healthy volunteers and those with early or mild Alzheimer's. The goal is to understand the biology behind sm…
Phase: NA • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Newborn blood spots may reveal hidden risks from common virus
Knowledge-focused Recruiting nowThis study analyzes dried blood spots from 630 newborns to find protein and RNA markers that could predict which babies with congenital CMV will develop hearing loss or other problems. Researchers will compare samples from infected babies who had complications, those who did not,…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Inner ear implant may boost brain function in balance disorder patients
Knowledge-focused Recruiting nowThis study looks at whether a vestibular implant (a device that helps with balance) can improve how people with severe inner ear damage perform tasks like staying upright, navigating, and thinking. About 20 people who already have the implant will be tested with it on and off, an…
Phase: NA • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Scientists hunt for clues to better treat HPV throat cancer
Knowledge-focused Recruiting nowThis study is collecting blood and tumor samples from 40 people with HPV-related oropharynx cancer to find biological markers that could predict how the disease will progress. Researchers will measure HPV DNA levels in the blood and analyze immune cells to better understand the b…
Sponsor: Regina Elena Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
5,000 patients to help unlock secrets of inflammatory heart disease
Knowledge-focused Recruiting nowThis study aims to learn how well heart scans (MRI, ultrasound, PET) can detect and predict outcomes in people with suspected or known inflammatory heart diseases. Researchers will follow 5,000 adults for one year to see how often heart involvement is confirmed and how it affects…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
New risk model may personalize Post-Chemo decisions for nasopharyngeal cancer
Knowledge-focused Recruiting nowThis observational study is testing whether a new tool called RAIRI can better identify which patients with nasopharyngeal cancer might benefit from additional therapy after standard chemoradiation. About 900 adults with non-metastatic disease will be followed to see if the RAIRI…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Could a simple nose clip help millions breathe easier and smell again?
Knowledge-focused Recruiting nowAbout 30 million US adults suffer from nasal sinus disease, often causing nasal obstruction and loss of smell. This study from Ohio State University will test a nasal plug (similar to a swimmer's nose clip) as a tool to better evaluate these symptoms. Researchers hope to develop …
Phase: NA • Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Can MRI predict radiation side effects before they happen?
Knowledge-focused Recruiting nowThis study uses repeated MRI scans after radiation therapy to see if they can predict normal tissue damage, like bone death (osteoradionecrosis), in patients with oral cavity or skull base tumors. Researchers will track changes in imaging over time and link them to radiation dose…
Phase: PHASE4 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New decision aid aims to reduce surgery regret for rhinitis patients
Knowledge-focused Recruiting nowThis study tests a printed decision aid that helps people with chronic hypertrophic rhinitis compare five surgical options. About 158 participants will either get standard counseling or the extra aid. Researchers will measure how certain patients feel about their choice and wheth…
Phase: NA • Sponsor: Taipei Medical University Shuang Ho Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Chilly workout secrets: study probes sex differences in fat burning
Knowledge-focused Recruiting nowThis pilot study from Colorado State University will test 20 healthy adults (ages 18-40) to see if cold temperatures change how the body burns fat during exercise, and whether that change differs between females and males. Participants will exercise in both a normal room and a ve…
Phase: NA • Sponsor: Colorado State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Lab-Grown tumor clones could guide cancer therapy
Knowledge-focused Recruiting nowThis study aims to grow miniature versions of head and neck tumors, called organoids, from patient samples. Researchers will test different cancer drugs on these organoids to see which ones work best. The goal is to eventually use this approach to tailor treatments to each patien…
Sponsor: Centre Francois Baclesse • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Can a simple test predict who will beat advanced nose cancer?
Knowledge-focused Recruiting nowThis study looks at 50 people with nasopharyngeal cancer that has come back or spread. Researchers will use advanced lab tests (multi-omics) to see if they can predict how well a combination of chemotherapy, radiation, and immunotherapy works. The goal is to find better ways to p…
Sponsor: Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
New study tracks sinus health in kids with cystic fibrosis on breakthrough drugs
Knowledge-focused Recruiting nowThis study follows 80 children aged 2-8 with cystic fibrosis to see how highly effective CF drugs (Kalydeco or Trikafta) impact sinus disease and sense of smell. Researchers will use MRI scans, smell tests, and quality-of-life surveys over two years. The goal is to understand whe…
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
AI chatbot takes on oral cancer ignorance in new study
Knowledge-focused Recruiting nowThis study compares an AI-powered chatbot to traditional educational handouts for teaching African American adults about oral cancer. Researchers want to see which method helps people learn more about prevention, risk factors, and early signs. The goal is to find better ways to s…
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Cancer immunotherapy may weaken bones, new study warns
Knowledge-focused Recruiting nowThis study looks at how immunotherapy drugs (anti-PD-1) affect bone strength in people being treated for cancer. Researchers will measure bone density and blood markers over a year in 25 patients. The goal is to understand if these treatments increase fracture risk, so doctors ca…
Phase: NA • Sponsor: Jessica Mezzanotte Sharpe • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
5,000 patients worldwide to help perfect cancer staging system
Knowledge-focused Recruiting nowThis international study aims to improve how doctors stage nasopharyngeal cancer by collecting data from 5,000 patients across multiple countries. Researchers will use this information to refine the TNM staging system and combine it with other factors like biomarkers. The goal is…
Sponsor: The University of Hong Kong-Shenzhen Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
530 hay fever volunteers needed to stop thunderstorm asthma attacks
Knowledge-focused Recruiting nowThis study is looking for 530 adults with hay fever in South-Eastern Australia to help create a tool that predicts thunderstorm asthma. Participants will have allergy and lung function tests, then track their symptoms during spring for two years. The goal is to find warning signs…
Phase: NA • Sponsor: University of Melbourne • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Nasal spray test could make allergy shots smarter and cheaper
Knowledge-focused Recruiting nowThis study is testing whether a nasal allergen provocation test (NAPT) can help doctors start and monitor allergy immunotherapy more effectively. Researchers will follow 200 adults with allergic rhinitis who are beginning immunotherapy, using the NAPT along with blood tests and s…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
World's largest Takayasu's registry launches to unlock disease secrets
Knowledge-focused Recruiting nowThis global registry is collecting information from 1,000 people with Takayasu's arteritis, a rare disease that inflames and narrows large arteries. Researchers will analyze patients' symptoms, lab results, imaging, and treatments to see how the disease behaves and is managed aro…
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
New study aims to spare oral cancer patients from unnecessary neck surgery
Knowledge-focused Recruiting nowThis study looks at whether a feature called tumor budding can help doctors decide if early-stage oral cancer patients need neck lymph node removal. About 524 participants will be randomly assigned to either have the main tumor removed alone or also have neck dissection. The goal…
Phase: NA • Sponsor: Jinsong Hou • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Researchers track Real-World treatment of serious ENT infections
Knowledge-focused Recruiting nowThis study is observing how doctors manage complicated infections of the ears, nose, throat, and neck in both children and adults. Researchers will track standard treatments like surgery or medication to understand current practices. No new treatments are being tested; the goal i…
Sponsor: University Medical Centre Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
New study tracks Real-World care for sinonasal and Skull-Base tumours
Knowledge-focused Recruiting nowThis study is observing 120 patients with sinonasal or skull-base tumours at a specialist ear, nose, and throat centre. Researchers are tracking how these conditions are managed, what the outcomes are, and how patients' quality of life changes. The goal is to better understand cu…
Sponsor: University Medical Centre Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Scientists gather data to unlock secrets of hearing and balance
Knowledge-focused Recruiting nowThis study collects medical information and samples from people with hearing, balance, taste, smell, voice, speech, or language disorders. Researchers aim to use this data for future studies and to find candidates for other research. Participants receive standard care, and no exp…
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Blood test may predict throat cancer comeback
Knowledge-focused Recruiting nowThis study looks at 220 people with HPV-related oropharynx cancer to see if certain gene mutations (TRAF3 and CYLD) and levels of HPV DNA in the blood can predict if the cancer will come back after treatment. Participants give blood samples and fill out quality-of-life questionna…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Simple test for throat cancer on the horizon?
Knowledge-focused Recruiting nowThis study from Mayo Clinic aims to find biological markers (biomarkers) in blood, tissue, and saliva that can signal the presence or absence of HPV-related oropharyngeal cancer. Researchers will follow 560 participants, including patients with and without the disease, to see if …
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Sinus implant safety checked in japan
Knowledge-focused Recruiting nowThis study is checking how safe and effective the Propel sinus implant family is when used as part of standard care for chronic rhinosinusitis in Japan. About 100 people who have had sinus surgery will be followed for 3 months. The main goal is to see how their symptoms change us…
Sponsor: Medtronic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Vision and balance: new exercise study seeks volunteers
Knowledge-focused Recruiting nowThis study looks at whether a balance exercise called IVA is safe and helpful for adults who have vision problems, with or without inner-ear balance issues. Researchers will compare two groups: people with vision problems only and those with both vision and inner-ear problems. Pa…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New study aims to unlock secrets of oral cancer through tissue and symptom tracking
Knowledge-focused Recruiting nowThis study is for 1000 people with oral cancer or precancerous mouth lesions. Researchers will collect tissue samples and ask participants about their symptoms before, during, and after treatment. The goal is to find better ways to predict how the disease will behave and which tr…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Can blood tests predict who will do their swallowing exercises?
Knowledge-focused Recruiting nowThis study looks at why people with head and neck cancer follow (or don't follow) swallowing exercises after radiation. Researchers will use blood tests and questionnaires to see if immune system proteins or feelings about the disease affect exercise habits. The goal is to find w…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Teachers' hidden struggle: could noise sensitivity be fueling job stress?
Knowledge-focused Recruiting nowThis study looks at how common hyperacusis (sensitivity to everyday sounds) and misophonia (strong negative reactions to specific sounds) are among teachers, and whether these conditions add to their work stress. Researchers will survey 500 teachers in Turkey to measure these sen…
Sponsor: Ondokuz Mayıs University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Vertigo and stress: new study probes the nervous system link
Knowledge-focused Recruiting nowThis study is looking at whether people with benign paroxysmal positional vertigo (BPPV) have differences in their autonomic nervous system compared to healthy people. Researchers will measure heart rate variability (HRV) in 104 participants (52 with BPPV and 52 matched controls)…
Sponsor: Istanbul Aydın University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Scientists probe blood vessel role in skin disorders
Knowledge-focused Recruiting nowThis study looks at how abnormal blood vessel growth (angiogenesis) contributes to various skin diseases like rosacea, psoriasis, and certain tumors. Researchers will collect skin samples from 85 volunteers aged 16 and older to analyze markers of angiogenesis. The goal is to bett…
Sponsor: University of California, Irvine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Stanford launches massive study to track oropharyngeal cancer over time
Knowledge-focused Recruiting nowThis study aims to learn more about oropharyngeal carcinoma, a type of throat cancer that can be linked to HPV. Researchers will collect blood samples from 1,000 patients before treatment and at six follow-up visits, and also gather tumor tissue when available. The goal is to bet…
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Scientists seek clues to mysterious childhood fever syndrome
Knowledge-focused Recruiting nowThis study aims to learn more about PFAPA, a condition that causes repeated fevers, sore throats, and mouth sores in children. Researchers will collect blood, saliva, stool, and tonsil tissue from 1,500 people with PFAPA or other tonsil problems. No treatment is given; the goal i…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Scientists hunt for genetic clues to Menière's disease
Knowledge-focused Recruiting nowThis study aims to uncover genetic and biological differences between people with Menière's disease, those with vestibular migraine, and healthy individuals. Researchers will analyze blood samples from 250 participants to look for specific gene variations and biohumoral factors. …
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
VR game helps scientists understand balance problems in kids
Knowledge-focused Recruiting nowThis study tests a virtual reality (VR) game to measure hand-eye coordination in children aged 7 to 17 with and without chronic balance (vestibular) disorders. Researchers want to see if the VR tasks are reliable and fun for kids, and how balance problems affect coordination. The…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Massive european study launches to unlock secrets of rare head and neck cancers
Knowledge-focused Recruiting nowThis large observational registry aims to collect data from over 13,000 adults across Europe with rare head and neck cancers, including cancers of the nasopharynx, nasal cavity, salivary glands, and middle ear. Researchers will track patient outcomes like survival, treatment resp…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
7-Year asthma study aims to uncover hidden disease patterns
Knowledge-focused Recruiting nowThis study follows 1,200 adults with asthma (with or without nasal polyps) for up to 7 years to see how their condition changes over time. Researchers will track symptoms, treatments, and biomarkers in blood and breath. The goal is to better understand different types of asthma a…
Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
New tool aims to predict cancer treatment toxicity in older patients
Knowledge-focused Recruiting nowThis study is testing a new tool designed to predict side effects from cancer treatment in elderly patients (70+) with advanced head and neck cancer. The goal is to see if the tool can help doctors choose safer treatments. Only 3 participants are being enrolled, making this a ver…
Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New study tracks RSV ear infections in kids
Knowledge-focused Recruiting nowThis study looks at how often young children get ear infections from RSV, a common virus. Researchers will track 1900 children under 2 years old to see how many have RSV-related ear infections, with or without bronchiolitis. The goal is to better understand the burden of RSV in t…
Phase: NA • Sponsor: Association Clinique Thérapeutique Infantile du val de Marne • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Ear fluid study aims to identify Infection-Causing bacteria in kids
Knowledge-focused Recruiting nowThis study collects a small sample of fluid from the ears of children aged 3 months to 15 years who have a draining ear infection (otorrhea). The goal is to identify which bacteria are present using standard lab tests and newer molecular methods. By understanding the bacterial ca…
Sponsor: Association Clinique Thérapeutique Infantile du val de Marne • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Sinusitis secrets: could a salt channel be the culprit?
Knowledge-focused Recruiting nowThis study looks at whether a partial problem with a salt channel (CFTR) in the nose contributes to chronic sinusitis. Researchers will measure how well the nose clears mucus in 20 people with sinusitis and healthy volunteers. The goal is to understand the disease better, not to …
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Braces for better breathing? study tests if jaw realignment opens airways in children
Knowledge-focused Recruiting nowThis study looks at whether orthodontic treatments like Twin Block and Hyrax appliances can improve breathing in children aged 8-14 with small jaws and narrow upper airways. Researchers will use 3D scans to measure changes in airway shape and airflow. The goal is to understand if…
Phase: NA • Sponsor: University of Alberta • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Blood test could revolutionize throat cancer monitoring
Knowledge-focused Recruiting nowThis study is testing a blood test that looks for tiny pieces of cancer DNA in the bloodstream of people with throat cancer. The goal is to see if this test can track how well treatment is working and spot if the cancer comes back earlier than current methods. Researchers will co…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Massive study monitors how pneumococcal vaccines change bacteria in kids
Knowledge-focused Recruiting nowThis large observational study is checking how pneumococcal vaccines have changed the types of bacteria living in children's noses. Researchers will compare healthy children and those with ear infections to see which bacterial strains are present and whether they resist antibioti…
Phase: NA • Sponsor: Association Clinique Thérapeutique Infantile du val de Marne • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New turkish dizziness tool could improve diagnosis
Knowledge-focused Recruiting nowThis study aims to translate and test the Situational Vertigo Questionnaire (SVQ) in Turkish. The SVQ measures dizziness triggered by visual environments like supermarkets or driving. Researchers will check if the Turkish version is valid and reliable by comparing it with other d…
Sponsor: Istanbul Medipol University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Personalized allergy shots for kids: a new hope for mite sufferers?
Knowledge-focused Recruiting nowThis study looks at 1,000 children (ages 5-18) with dust mite allergies to see if customizing allergy shots based on their specific mite protein sensitivities leads to better symptom control. Participants get a detailed blood test to map their allergy profile and are followed for…
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Scientists investigate whether tiny microbes fuel head and neck tumors
Knowledge-focused Recruiting nowThis study looks at whether changes in the bacteria living in your mouth and gut (the microbiome) are linked to head and neck cancer. Researchers will collect stool and saliva samples from 60 people—half with cancer and half without—to compare their microbial makeup. The goal is …
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
New study explores why cancer patients lose their appetite
Knowledge-focused Recruiting nowThis study looks at how cancer and its treatments change a person's sense of taste and smell, and how that affects their eating and nutrition. Researchers will follow 306 people newly diagnosed with cancer of the mouth, throat, colon, or liver. They will use questionnaires, taste…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Can treating your mind and allergies together improve symptoms?
Knowledge-focused Recruiting nowThis study explores whether people who seek help for both their allergies and their mental health (like anxiety or depression) have better control over their symptoms. Researchers will look at health records from 200,000 adults over several years. The goal is to understand if com…
Sponsor: QHSLab, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
20,000 volunteers needed to unlock throat cancer early detection
Knowledge-focused Recruiting nowThis study aims to find out how many healthy adults over 40 carry high-risk HPV in their mouth, which can lead to oropharyngeal cancer. Researchers will test 20,000 volunteers in the Czech Republic to develop a better screening method. The goal is to identify people at risk earli…
Phase: NA • Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Liquid biopsy trial aims to outsmart HPV cancers
Knowledge-focused Recruiting nowThis study is testing whether liquid biopsies (blood tests that look for bits of HPV and tumor DNA) can help doctors monitor treatment and spot early signs of cancer returning in people with HPV-related cervical and oropharyngeal cancers. Researchers will follow 480 participants …
Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
School air study aims to uncover hidden triggers for Kids' allergies
Knowledge-focused Recruiting nowThis study looks at how indoor air and dust pollutants in classrooms impact children's allergies and lung function. Researchers will monitor 100 children, comparing those with allergies to those without, using questionnaires, allergy tests, and breathing tests. The goal is to ide…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Massive study tracks 1,000 people to unlock secrets of eczema remission
Knowledge-focused Recruiting nowThis long-term study follows 1,000 people with eczema and related allergies, plus healthy volunteers, to see what factors help the disease go into remission. Researchers will collect medical and lifestyle data to find patterns and possible biomarkers. The goal is to better unders…
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Could your DNA hold the key to preventing hearing loss?
Knowledge-focused Recruiting nowThis study aims to understand why people with Turner syndrome often lose their hearing. Researchers will look at genetic and epigenetic markers in 150 adults aged 18-60. Participants will have hearing, balance, blood, and imaging tests. The goal is to find new ways to treat or de…
Sponsor: Gødstrup Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Pregnancy and vasculitis: new study seeks answers
Knowledge-focused Recruiting nowThis study tracks the pregnancy experiences of women with vasculitis, a group of rare diseases causing blood vessel inflammation. Researchers will use online surveys to understand how vasculitis affects pregnancy and what outcomes occur. The goal is to gather information to help …
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Scientists build tissue bank to unlock vasculitis mysteries
Knowledge-focused Recruiting nowThis study collects tissue samples from 1,000 people with various forms of vasculitis, a group of rare inflammatory blood vessel diseases. Researchers will analyze the samples alongside clinical data to identify genes that increase risk and to spark new ideas for diagnosis and tr…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Survey aims to uncover hidden struggles of rare artery disease
Knowledge-focused Recruiting nowThis study uses two online questionnaires to learn about the experiences of people with Takayasu arteritis and how doctors manage the condition. About 50 patients and an unspecified number of physicians in the UK will share their views on symptoms, treatment priorities, and unmet…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New study aims to curb antibiotic overuse for coughs and colds
Knowledge-focused Recruiting nowThis study tests whether a two-part approach—improving communication about viral infections and having pharmacists double-check prescription lengths—can reduce how many days antibiotics are prescribed for respiratory infections like bronchitis, sinusitis, and sore throat. About 4…
Phase: NA • Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
DNA hunt for vasculitis genes opens new doors
Knowledge-focused Recruiting nowThis study collects DNA samples and medical information from 1,000 people with various forms of vasculitis (blood vessel inflammation). Researchers will analyze the data to identify genes that increase the risk of developing these severe diseases. The goal is to better understand…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Can you sense motion? new study seeks answers for balance disorders
Knowledge-focused Recruiting nowThis study measures how well people with and without vestibular (balance) disease can sense motion through vision and balance. Researchers hope to learn how aging and disease change motion perception. About 300 healthy adults and patients with balance disorders will participate i…
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Nose packing duration linked to sore throat risk after surgery?
Knowledge-focused Recruiting nowThis study observes 100 adults aged 20–40 who are having nose surgery (septorhinoplasty) to see if the length of time nasal packing is left in place affects the development of sore throat or pharyngitis. Participants will have their sore throat, swallowing difficulty, and throat …
Sponsor: Al-Azhar University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
New questionnaire aims to simplify allergy tracking in doctor visits
Knowledge-focused Recruiting nowThis study is testing whether a simple symptom score questionnaire (SCST) is acceptable and useful for patients with allergic rhinitis during ENT check-ups. The goal is to see if this tool helps doctors monitor severity and response to treatment consistently. Thirty adults will p…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Balance trouble linked to reading struggles in kids with hearing loss
Knowledge-focused Recruiting nowThis study looks at whether inner-ear balance (vestibular) problems make reading harder for children with hearing loss. Researchers will test 90 children, some with normal hearing and some with severe hearing loss, measuring their ability to see clearly during head movements and …
Phase: NA • Sponsor: Father Flanagan's Boys' Home • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Sleep troubles may worsen vertigo in Ménière's patients
Knowledge-focused Recruiting nowThis study looks at whether sleep disorders make vertigo worse for people with Ménière's disease, a condition that causes hearing loss, ringing in the ears, and dizziness. Researchers will track 100 adults to see if those with more severe vertigo also have more sleep problems. Th…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Blood test may tell which oral cancer patients need more chemo
Knowledge-focused Recruiting nowThis study looks at whether a blood test that finds circulating tumor cells (CTCs) can help decide if oral cancer patients need extra chemotherapy after standard treatment. About 100 patients who have completed surgery and chemoradiotherapy will be tested. If their CTC count is h…
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Lost your sense of smell or taste? researchers want to track your recovery
Knowledge-focused Recruiting nowThis study is a registry that follows 500 people with smell or taste disorders to learn more about how these conditions progress and affect quality of life. Participants complete standard tests and questionnaires during their clinic visits. The goal is to better understand these …
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
New study aims to uncover hidden health impacts of rare blood vessel diseases
Knowledge-focused Recruiting nowThis study looks at how two rare diseases that cause blood vessel inflammation—Takayasu arteritis and Behçet's disease—affect physical strength, breathing, daily function, and emotional well-being. Researchers will compare 30 participants (patients and healthy volunteers) using s…
Sponsor: ÖZLEM NUR TOK YAMAN • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Massive study aims to find best throat cancer treatment
Knowledge-focused Recruiting nowThis study is tracking 1000 people with throat cancer to compare different treatments like surgery, radiation, and chemotherapy. The goal is to see which treatments lead to the best survival rates and preserve the ability to speak and swallow. Participants are aged 18-90 with var…
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
New study seeks biomarkers to personalize radiation for nasopharyngeal cancer
Knowledge-focused Recruiting nowThis study enrolls 500 adults with nasopharyngeal carcinoma (stage I-III) who are receiving chemoradiotherapy with either proton or photon radiation. Researchers will collect imaging scans and blood samples to find markers that predict how well the cancer responds, side effects, …
Sponsor: Cheng-En Hsieh • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Scientists probe why oral cancer hurts so much
Knowledge-focused Recruiting nowThis study compares pain sensitivity between 40 oral cancer patients and 40 healthy volunteers using pressure and tongue-stretch tests. Researchers aim to understand how nerve cells called Schwann cells contribute to oral cancer pain. No treatment is given; the goal is to gather …
Phase: NA • Sponsor: New York University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Blood test may spare throat cancer patients from radiation side effects
Knowledge-focused Recruiting nowThis study is for people with HPV-related throat cancer who have surgery to remove their tumor. Researchers are testing whether a blood test that looks for leftover tumor DNA can safely identify patients who do not need additional radiation. The goal is to reduce side effects by …
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Scientists hunt for cancer clues in sputum and tissue samples
Knowledge-focused Recruiting nowThis research study collects sputum and tissue samples from 700 people with precancerous changes or certain cancers (lung, head and neck, esophageal). The goal is to find biomarkers—biological signs—that could help understand or detect these cancers earlier. Participants include …
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Researchers track rare artery disease affecting the lungs
Knowledge-focused Recruiting nowThis study follows 150 people with Takayasu's arteritis that also affects the lung arteries. Researchers will track their health over time, including how far they can walk in six minutes and their risk of death. The goal is to better understand the disease and its long-term outlo…
Sponsor: China-Japan Friendship Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Study maps hidden nerve damage in head and neck cancer survivors
Knowledge-focused Recruiting nowThis study looks at nerve-related problems like numbness, tingling, and pain in people who have been treated for oral cavity or throat cancer. Researchers will use simple tools like brushes and temperature tests to map these sensations. The goal is to better understand how common…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:45 UTC